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Preface 
 
 
In this work I will present the results obtained in the last three 
years of my career during my post-graduate studies in Genetics and 
Molecular Biology, with a main focus on two projects that I ran in 
the Prof. Irene Bozzoni's lab at Sapienza University of Rome.  
The first project that I will discuss is about a long non-coding RNA 
that was discovered in the lab while I was working at my master's 
degree thesis (Cesana et al., 2011), named linc-MD1. We found 
that this molecule is able to induce differentiation of myoblasts by 
acting as a decoy for two microRNAs, miR-133 and miR-135, 
thereby releasing the expression of their natural targets. During the 
ending of my master's and the beginning of my PhD, I worked on a 
follow-up project regarding linc-MD1 biosynthesis and found that 
one of the targets of miR-133 is the RNA binding protein HuR, 
which in turn sustains linc-MD1 production by inhibiting its 
cleavage by the RNase Drosha (Legnini et al., 2014). These results, 
as they have been published two years ago and were part of a 
project that I started before my post-graduate education, will be 
included in a dedicated section of the introduction chapter, after 
briefly reviewing the minimal knowledge about the biology of 
muscle differentiation and the problem of non-coding RNA needed 
to appropriately understand the frame of this work. A brief part 
about different approaches to quantitative modelling of how 
microRNA decoys can work will follow (a field I was not directly 
involved in, but that I actively followed and discussed about with 
some of the authors of the papers that I will present). I will finally 
introduce the second main project I've been working on, that is the 
primary object of this thesis, about a new and enigmatic class of 
RNA molecules named circular RNAs. These molecules originate 
as covalently closed ribonucleic chains after a particular splicing 
reaction called back-splicing, they are present across the whole 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 5  
eukaryotic domain and they are particularly abundant in mammals. 
Although some key features of their biosynthesis have been 
recently revealed, almost nothing is known about their function. In 
this work I tried to understand the basis of circular RNA 
expression dynamics in muscle differentiation and found that they 
seem to exert important functions in such biological process. After 
reeling off the little but fundamental knowledge accumulated about 
circular RNAs over the past couple of years, I will discuss the aim 
of this thesis and start describing the results I obtained. Discussion 
will be included in the same chapter, as each of the main findings 
will be described and commented at the same time. Some general 
concluding remarks are reported in the following chapter. Finally, 
after a detailed description of the techniques used in this work and 
a brief glossary for the non-expert reader, I will list the 
bibliography cited in the thesis and the publications I've been 
involved in as an author, together with a synopsis of the findings of 
each paper and my contribution to them. 
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Summary 
 
 
Skeletal myogenesis is a well-characterized biological process 
driving the formation of the adult muscle tissue from mesodermal 
progenitors. The key molecular and cellular steps of such process 
can be replicated in vitro, by culturing muscle precursor cells 
called myoblasts, which can be induced to differentiate into mature 
myotubes. We characterized the role of a long non-coding RNA, 
linc-MD1, in regulating in vitro differentiation of murine 
myoblasts by acting as a molecular decoy for two microRNAs, 
miR-133 and miR-135, and we further dissected the regulation of 
linc-MD1 biosynthesis by the RNA binding protein HuR. 
Searching for new non-canonical RNA species involved in 
myogenesis, we directed our attention to circular RNAs 
(circRNAs). Circular RNAs are produced by the spliceosome via a 
particular reaction called back-splicing, which links a donor splice 
site to an upstream acceptor site, thereby generating a covalently 
closed RNA molecule. We performed high-throughput expression 
profiling of circRNAs in murine and human cells and studied the 
principles of their regulation during myogenesis. We then applied a 
high-content functional genomic screen of conserved circRNAs 
and found that these molecules are actively involved in the control 
of myoblasts differentiation. Among them, we further 
characterized circ-ZNF609 and found that it is able to control 
myoblast proliferation, providing the first example of a circular 
RNA involved in a relevant biological process. Moreover, 
sequence and biochemical analyses suggested that circ-ZNF609 
might be translated in a functional protein, representing a possible 
molecular mechanism for circRNA function. 
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Introduction 
 
 
1. Muscle differentiation from embryology to the new 
frontiers of genomic science. 
 
1.1 The core myogenic gene expression program relies on a 
transcriptional activation cascade. 
The development of the skeletal muscle system of vertebrates 
occurs through a complex series of morphogenetic events, globally 
called myogenesis. During embryo development, muscles of the 
trunk and limbs originate from progenitor cells located in the 
somites which are able to respond to inductive signals, mainly 
coming from the notochord and the neural tube, with the activation 
of a muscle-specific gene expression program (Asakura et al., 
2002). Those proliferating cells, also called myoblasts, are able to 
delaminate and migrate, eventually entering the differentiation 
stage that leads to the formation of mature myotubes (figure 1). 
Differentiation of myoblats into myotubes involves three key steps: 
cell cycle arrest, orientation and cell fusion. Myogenesis occurs 
also in the adult life to allow muscle growth and maintenance or 
after exercise and injury, and it is usually initiated by a population 
of stem cells located at the periphery of muscle fibers, known as 
satellite cells. The whole process of differentiation is directed by a 
complex gene expression program initiated with the contribution of 
a specific group of transcription factors called myogenic regulatory 
factors (MRFs). 
MRFs expression is tightly regulated in time and space, restricted 
to the muscle tissue and leads to the activation of the core gene 
expression program required for muscle differentiation. They all 
contain a basic helix-loop-helix domain which is able to recognise 
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the consensus binding motif CANNTG, known as E-box, in 
enhancer and promoters of muscle-specific genes (Tapscott, 2005). 
Certain MRFs are required for the initial specification of muscle 
progenitor cells into myoblasts and sustain their proliferative state, 
whereas other factors, subsequently activated by the early ones, 
control the terminal differentiation stage of myoblasts. The master 
genes of myoblast specification are Myogenic factor 5 (Myf5) and 
Myogenic Differentiation 1 (MyoD). Although they're not 
expressed exactly at the same time during embryogenesis, only 
knock-out mice for both factors have complete deficiency of 
muscle-tissue, while single knock-outs do not, indicating that these  
two MRFs act in a redundant fashion, thereby providing robustness 
to the myogenic program (Rudnicki et al., 1993). Early MRFs are 
regulated by the paired domain and homeobox-containing proteins 
Pax3 and Pax7. While the first is more active in the embryo (in 
turn activated by Six and Eya family proteins (Bajard et al., 2006), 
the second is the key activator of adult myogenesis, being a 
common marker of activated satellite cells (Seale et al., 2003). 
Terminal differentiation of myoblasts is driven by a second 
activation cascade of gene expression led by later MRFs, including 
Myogenin and Mrf4 (also called Myf6). While Mrf4 plays a role in 
progenitor cells specification with MyoD and Myf5 (Hasty et al., 
1993 and Patapoutian et al., 1995), Myogenin is considered the 
typical late myogenic factor, whose action is required for 
transcription of the genes necessary for the architecture and 
function of mature muscle fibers (e.g. myosins, muscle creatine 
kinase, dystrophin etc,). MRFs act together with the Serum 
Response Factor (SRF) and another family of transcription factors, 
known as Myocyte Enhancing Factor 2 family (MEF2) which 
contain a MADS box domain and are able to bind DNA carrying a 
CC[A/T]6GG motif (CarG-box) (Dodou et al., 2003). It has also 
been shown that the protein Mastermind-like 1 (Maml1), known 
for participating in in the Notch signaling pathway, has also a 
Notch-independent function in the muscle lineage, being able to 
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form a transcriptional activator complex with the Mef2 family 
member Mef2C (Wilson-Rawls et al. 1999). 
Myoblasts differentiation can be replicated in vitro by culturing 
myoblasts or satellite cells in growth factors-containing media that 
keep the cells proliferating, until these are confluent enough to 
touch one another and eventually are exposed to serum starvation. 
In these conditions, cultured cells are able to exit the cell cycle, 
orientate and eventually fuse into multi-nucleated syncytia as 
happening in naturally occurring differentiation (Yaffe et al., 1965, 
figure 2). 
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Figure 1 
 
Figure 1. Schematic representation of the differentiation stages from progenitor 
muscle cells to terminally differentiated fibres is shown. The cells are labelled 
with the characteristic proteins that are expressed at each stage. These include 
master transcription factors that regulate the switch from one stage to the 
following one - such as paired box protein Pax‑3 (PAX3), PAX7, myogenic 
factor 5 (MYF5), myoblast determination protein (MYOD), myocyte enhancer 
factor 2C (MEF2C) and myogenin - as well as the late myogenic proteins 
dystrophin, utrophin and myosin123. The graph shows the corresponding 
temporal expression patterns of selected non-coding RNAs. Adapted from Fatica 
et al., (2015), reproduced under licence N° 3786520528882. 
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Figure 2 
Figure 2. Bright-field pictures of in vitro cultured human primary myoblasts at 
different times of differentiation (hours). Cells are initially observed as single 
disordered objects, then they elongate and become aligned, eventually they fuse 
to form myotubes. 
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1.2 The study of non-coding RNAs and system biology 
approaches add new information on myogenesis. 
Not only transcription factors participate to defining the myogenic 
gene expression program: more recently, also non-coding RNAs 
have been linked to the regulation of myogenesis (figure 1). Recent 
studies revealed that myoblasts proliferation, differentiation and 
muscle physiology are also regulated by a set of muscle-specific 
microRNAs, whose expression is directly induced by myogenic 
transcription factors. The best widely studied muscle-specific 
microRNAs belong to the miR-1 and miR-133 families. These 
microRNAs are produced from three bi-cistronic clusters: miR-1-
1/miR-133a-2, miR-1-2/miR-133a-1 and miR-206/miR-133b. 
Another group of muscle-specific microRNAs is the miR-208a/b 
family, whose sequence is embedded in the MYH6 and MYH7 
myosin genes, and whose expression is restricted to 
cardiomyocytes, where they play a relevant role in cardiac 
development and stress-dependent remodelling (van Rooij et al., 
2007). The pivotal role of microRNAs in muscle biology was 
demonstrated by analysing Dicer-null mice, which have severe 
cardiac defects (da Costa Martins et al., 2007). Moreover, 
transcriptional activation of the miR-1/miR-133a loci relies on the 
binding of MyoD, MEF2 and SRF, thus implying a possible part of 
these molecules in the MyoD-dependent control of differentiation 
(Zhao et al., 2005 and Rao et al., 2006). Several studies 
demonstrated a central role of these microRNAs in myoblasts 
proliferation and differentiation, a role fulfilled by blocking the 
expression of genes like CyclinD2, Cdc42, IRX5, SRF, 
Connexin43, HDAC4, G6PD and many others (Chen et al., 2006 
and Cacchiarelli et al. 2010). MiR-206 is likely to have an 
independent function, as it is able to control the activation of 
satellite cells by repressing Pax7 (Cacchiarelli et al. 2010), besides 
a common function in myoblasts where it targets multiple genes 
responsible for proliferation (Anderson et al., 2006 and Gagan et 
al., 2012). Another important role is played by miR-31, which is a 
ubiquitous microRNA, very abundant in proliferating myoblasts 
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and down-regulated after differentiation. It is able to target 
Dystrophin (Cacchiarelli et al., 2011), a tardive marker of mature 
myotubes, but also Myf5, a target that may result paradoxical for 
the expression pattern of miR-31. On the contrary, in quiescent 
satellite cells, which are primed for myogenesis but are poised until 
the proper external signals occur, miR-31 activity is crucial, as the 
targeting of Myf5 prevents the cells entering the active 
proliferative state that foreshadows their differentiation. Such 
block is conveniently transient, since the Myf5 mRNA is confined 
to mRNP granules where it is stored until activation of quiescent 
cells occurs (Crist et al., 2012). 
Although that complex gene expression regulatory network, made 
of transcription factors and microRNAs, has been deeply dissected 
in each of its single components, a system biology approach to 
understand the general principles behind the regulation of 
myogenesis in time and space is still lacking. A few efforts for 
capturing a more global picture of the regulatory events occurring 
in myoblast differentiation have been made in the recent past.  
Particularly, the rise of single cell sequencing allowed dissecting 
the trajectory of the myogenic gene expression program by using 
an approach called pseudo-temporal ordering. One of main 
obstacles to the exact understanding of the temporal evolution of 
the transcriptome in cell populations is their asynchronicity. 
Sequencing RNA from many single cells within a population 
instead of the bulk itself allows dramatically increasing the 
information regarding the multiple states where those cells lie 
during their differentiation. By minimizing the distance in terms of 
gene expression between those states and maximizing the distance 
between the first and the last state, an algorithm called Monocle is 
able to create a pseudo-temporal trajectory that may correspond to 
the actual temporal evolution of a given cell during differentiation 
(Trapnell et al., 2014). 
Another example is a ChIP-seq study of MyoD and Myogenin, 
which revealed that such transcription factors, in addition to well-
Ivano Legnini 
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known muscle-specific genes, extensively bind to extra-genic 
regions enriched for H3K4 monomethylation, a landmark of 
enhancer activity (Mousavi et al., 2013). Those regions were also 
enriched for H3K27 acetylation and PolII and, as expected, peaks 
of RNA synthesis were mapped to the same sites. Such enhancer 
RNAs (eRNAs) were found also in previously known MyoD 
activating elements, playing an active role in chromatin 
remodelling of its own locus.  
A third important contribution to a wider understanding of 
myogenesis from the point of view of the transcriptome consisted 
of the profiling of long non-coding RNAs during in-vitro 
differentiation of murine myobalsts (Ballarino et al., 2015). In the 
past ten years, an unprecedented attention was directed towards 
long non-coding RNAs (lncRNAs) or large intervening non-coding 
RNAs (lincRNAs). Particularly, international projects such as 
Phantom and Encode revealed with dozens of genomic and 
transcriptomic reports that a large portion of the mammalian 
genomes is transcribed, producing a huge number of non-coding 
RNAs in a tissue-specific and regulated fashion. Many efforts were 
therefore focused on the understanding of the possible functions of 
long non-coding RNAs, finding that actually many of them can be 
involved in various biological processes (reviewed in Fatica et al., 
2013). In Ballarino et al. (2015), 29 new long non-coding RNAs 
whose expression was regulated during differentiation were 
annotated and experimentally validated. Among them, the long 
non-coding RNA lnc-31, which is the host transcript of miR-31, 
was identified as a crucial regulator of myoblast proliferation. This 
work followed the identification of the first long non-coding RNA 
involved in myogenesis, linc Muscle Differentiation 1, or linc-
MD1, to which the next paragraph will be dedicated. 
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2. The role of linc-MD1 and HuR in myogenesis. 
 
Note: some of the figures included in this section are part of two 
published papers whose copyright is owned by Elsevier (doi: 
10.1016/j.cell.2011.09.028 and 10.1016/j.molcel.2013.12.012). 
According to Elsevier copyright policy, their inclusion in this 
thesis does not constitute a copyright infringement (license N° 
3785820559384). 
 
2.1. The miR-206/133 locus produces a stable cytoplasmic long 
non coding RNA. 
MicroRNAs are usually processed from longer precursors in two 
steps of endonucleolytic cleavage. The first one is realized by 
Drosha, an component of the multi-protein complex called 
Microprocessor, which is loaded onto the nascent primary 
transcript (pri-miR), then recognises and cuts the common short 
hairpin structure that distinguishes almost all microRNA 
precursors. Pri-miRs can be protein-coding genes (carrying the 
short hairpin in introns or exons) but also non-coding transcripts, 
which were thought to exhaust their function by giving rise to the 
mature form of the embedded microRNA. The study of linc-MD1 
revealed that exactly like mRNAs, the non-coding product of a 
microRNA-containing gene can be functional on its own (Cesana 
et al., 2011). As described previously in this thesis, miR-206 and 
miR-133b are two fundamental myogenic factors and their 
expression is linked to the same genomic locus. While studying 
their biosynthesis, we discovered by 5’ RACE, ChIP and 
conservation analysis that such locus contains two main promoters 
(called Dist and Prox for “distal” and “proximal” to miR-
206/133b, figure 3), both bound by MyoD. While the second 
seems to produce mainly the microRNA precursor transcript, the 
distal regulatory element sustains the synthesis of a multi-exonic, 
polyadenylated stable RNA, linc-MD1. Such long non-coding 
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RNA is exported to the cytoplasm, where it seems crucial for the 
proper differentiation of murine myoblasts. 
 
2.2. Linc-MD1 acts as a decoy for miR-133 and miR-135. 
Given the fact that linc-MD1 is accumulated during in vitro 
myogenesis (figure 3), we speculated that it might be involved in 
such process. Two complementary approaches were used to test 
the supposition: siRNAs-mediated knock-down and cDNA 
overexpression from a plasmid vector, followed by western blot 
analysis of Myogenin and Myosin Heavy Chain, an early and late 
marker of differentiation respectively. As hypothesized, both of the 
markers were decreased as consequence of linc-MD1 down-
regulation and increased after up-regulation (figure 4). At this, 
point, we sought to understand the mechanism underlying such 
impact on myoblast differentiation. One idea came from some 
reports that had been published shortly before (Poliseno et al., 
2010 and Wang et al., 2010), stating that non-coding RNAs could 
act as “sponges” for microRNAs, thus regulating the expression of 
mRNAs that share a similar pool of microRNA target sites. The 
whole model relies on the idea that if two transcripts are targeted 
by the same microRNAs, a perturbation in the concentration of one 
of the two targets is transferred to the other because it impacts on 
the concentration of free (non-bound) microRNAs (Salmena et al., 
2011). We therefore looked for microRNA binding sites and their 
possible targets that could explain the pro-myogenic activity of 
linc-MD1. Bioinformatic predictions, confirmed by luciferase 
assays, revealed that two microRNAs, miR-133 and miR-135, are 
able to bind linc-MD1 sequence. We then screened possible targets 
of these two microRNAs for identifying genes that could be 
responsible for the phenotype associated to linc-MD1 modulation, 
and selected for further validation Maml1 and Mef2C. As stated 
before in this chapter, these two proteins are able to interact and 
form a transcriptional activator complex that sustains myogenesis. 
Again, knock-down and overexpression of linc-MD1 in the 
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presence and absence of the two microRNAs, as well as luciferase 
assays, were compatible with the model of the microRNA sponge, 
suggesting that linc-MD1 sustains Maml1 and Mef2C expression 
by sequestrating miR-133 and miR-135 (figure 5). 
But at this point a few questions were still open. First, how could 
linc-MD1 escape Drosha processing and accumulate in the 
cytoplasm of differentiating myoblasts? Second, what’s the 
functional meaning of a locus producing a microRNA and a decoy 
of the same microRNA? And third, what are the quantitative and 
qualitative requirements of linc-MD1 for being able to impact on 
microRNAs availability? I will try to answer those questions in the 
following paragraphs. 
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Figure 3 
Figure 3. The miR-206/133b locus produces a long non coding RNA. A. 
Genomic organization of the miR-206/133b locus with linc-MD1 exons (in 
black, an alternative 3’ end in grey), the two pre-microRNAs (in white), the 
conservation score in the middle and the regulatory elements at the bottom. B. 
RT-PCR analysis of linc-MD1, pri-miR-206 and 133b and HPRT is a loading 
control from undifferentiated and differentiated myoblasts (GM and DM), 
nuclear and cytoplasmic fractions, polyadenylated and non-polyadenylated 
fractions, as well as from undifferentiated and differentiated satellite cells and 
mouse embryo fibroblasts (MEF). Adapted from Cesana et al. (2011), 
reproduced under license N° 3785820559384.  
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Figure 4 
 
Figure 4. Knock-down and overexpression of linc-MD1 affects myoblasts 
differentiation. In the upper panels representative western blots for Myogenin 
and MHC in control and linc-MD1 knock-down (left) or overexpression (right) 
are shown. Below is shown a bar plot for western blot densitometric 
quantification of three independent experiments (white bars for Myogenin, grey 
bars for MHC). Black bar plots show linc-MD1 levels upon RNAi and 
overexpression. In the bottom panel a schematic representation of the vectors 
used for linc-MD1 overexpression is shown. Adapted from Cesana et al. (2011), 
reproduced under license N° 3785820559384.  
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Figure 5 
Figure 5. A. linc-MD1 regulates Maml1 and Mef2C in a microRNA-dependent 
manner. Western blot for Maml1 and Mef2C in control and linc-MD1 knock-
down (left blots) or overexpression (right blots) in the presence or absence of 
miR-133/135-blocking LNAs. HPRT is used as loading control. B. Upper panel 
shows the constructs tested in the lower panels. Lower panel: luciferase analysis 
of the Maml-1 and Mef2C 3’UTRs (WT or mutated in the miR-133/miR-135 
binding sites) upon overexpression of linc-MD1 (WT or mutated in miR-133/135 
binding sites. Adapted from Cesana et al. (2011), reproduced under license N° 
3785820559384.  
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2.3 A feed-forward regulatory loop between linc-MD1 and 
HuR regulates the timing of in vitro myoblasts differentiation. 
Very often in the history of molecular biology the observation of a 
gene producing a phenotype was explained by the postulation of a 
linear pathway, made of a series of elements connected one to each 
other hierarchically, tested by the observation of epistatic mutants 
or with complementation experiments. This view has been 
radically revised with the advent of system biology and -omic 
technologies, which try to capture the global picture of a biological 
phenomenon, confirming existing linear pathways but finding that 
those are usually embedded in much more intricate networks. In 
the case of linc-MD1, we were aware that not only two microRNA 
targets out of potential hundreds more could explain its function. 
We therefore looked for additional putative targets of miR-133 and 
miR-135 that could result interesting for understanding more about 
this gene. Among the predicted miR-133 targets, we found HuR 
(Legnini et al., 2014), a gene coding an RNA binding protein that 
is implicated in muscle differentiation, as it is able to confer 
stability to pro-myogenic mRNAs such as MyoD, Myogenin and 
p21 (Figueroa et al., 2003 and von Roretz et al., 2011). This 
protein interacts with a large number of RNAs (Lebedeva et al., 
2011 and Mukherjee et al., 2011) and the functional meaning of 
those interactions has been object of extensive study and 
speculation. One of the intriguing jobs of HuR is its ability to 
control microRNA biogenesis and microRNA target recognition. 
Particularly, it is able to block miR-7 biogenesis by direct binding 
to its precursor together with the RNA binding protein Musashi 2 
(Choudhury et al., 2013), and it can also compete or cooperate with 
the binding of specific microRNAs to their targets (Kim et al., 
2009 and Kundu et al., 2012). After validating HuR as a miR-133 
target and a linc-MD1-regulated gene (figure 6), we started 
investigating a possible physical interaction between the two. 
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Immunoprecipitation of HuR and RNA pull-down of linc-MD1 
confirmed the existence of such interaction, opening new 
fascinating scenarios (figure 7).  
We already knew the effect of linc-MD1 knock-down on HuR (as 
for other miR-133 targets) and we knew that their expression was 
tightly correlated during myoblast differentiation (figure 8A), but 
we missed information about HuR impact on linc-MD1. SiRNA-
mediated knock-down of HuR caused strong down-regulation of 
linc-MD1 (figure 8B and C), compatibly with an effect on 
biogenesis or on stability. We excluded the second hypothesis by 
RNA turnover analysis (performed with actinomycin D treatment 
followed by qRT-PCR) and found that HuR down-regulation 
caused Drosha to cleave more efficiently the miR-133b precursor 
sequence (figure 8C), as observed with the measurement of 5’cut-
off molecules and miR-133b after knock-down. Moreover, 
luciferase analysis revealed that HuR is able to cooperate with 
miR-135 binding to the linc-MD1 sequence (not shown). In order 
to elaborate a meaningful model of the linc-MD1/HuR feed-
forward regulatory loop and unravel the apparent paradox of the 
linc-MD1 locus producing miR-133b and its decoy alternatively, a 
couple of facts need to be mentioned. First, miR-133b is 
functionally identical to its paralogues miR-133a-1 and miR-133a-
2, coming from two unrelated loci and having much more Drosha-
compatible pri-miR structures. Second, the timing of expression of 
all those actors during myogenesis: while HuR and linc-MD1 are 
strongly but transiently up-regulated at the beginning of 
differentiation, the whole miR-133 pool is accumulated more 
lately, in mature myotubes (figure 8A). Therefore, although all 
those actors are to be considered pro-myogenic, they act in distinct 
time windows. At the beginning of differentiation, HuR and linc-
MD1 are activated (linc-MD1 at the transcriptional level, HuR we 
don’t know) and sustain each other expression at the post-
transcriptional level. During this window of time lasting 48-72 
hours, miR-133 activity is blocked by linc-MD1. Later on during 
differentiation, miR-133 is accumulated, mainly from the miR-
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133a loci and its concentration increases to a level that cannot be 
buffered by linc-MD1 anymore, resulting in HuR down-regulation 
and consequently on linc-MD1 biogenesis shutdown. At this stage, 
miR-133 is able to repress its targets, with the important 
consequence that such repression follows an on/off behaviour, 
rather than a continuous ascent, thanks to linc-MD1 activity in the 
previous phase (figure 9). Globally, those observations suggest that 
microRNA decoys can sharpen the temporal (and possibly spatial) 
frame of microRNA activity and can represent powerful switches 
to trigger the entry or exit of proteins and RNAs to or from 
feedback loops. 
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Figure 6 
Figure 6. Linc-MD1 regulates HuR expression. A. Schematic representation of 
the contructs used below (HuR 3’UTR cloned downstream to the luciferase 
ORF). B. Luciferase assay of the aforementioned constructs with miR-133 
inhibition mediated by LNAs and with linc-MD1 overexpression in the WT and 
mutated form (by deleting miR-133 binding sites). C. RT-PCR and Western blot 
analyses showing linc-MD1 and HuR expression upon knock-down and 
overexpression of linc-MD1 and upon miR-133 inhibition by LNAs. Adapted 
from Legnini et al., 2014, reproduced under the license N° 3785820559384.  
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Figure 7 
 
Figure 7. linc-MD1 is bound by HuR. A. HuR immunoprecipitation in mouse 
(upper panel) and human (lower panel myoblasts). RT-PCR for linc-MD1 is 
shown together with a positive control (MYOD) and a negative one (HPRT). B. 
RNA pulldown for linc-MD1 obtained wth antisense biotinylated probes. 
Western blot analysis for HuR and the negative control Actinin is shown. 
Adapted from Legnini et al., 2014, reproduced under the license N° 
3785820559384. 
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Figure 8  
Figure 8. linc-MD1 and HuR feedback regulation. A. HuR, linc-MD1 plus its 5’ 
cut-off product and miR-133 expression levels during in vitro myoblasts 
differentiation measured by Western Blot, RT-PCR and Northern blot 
respectively (Hprt, U6 snRNA and 5S rRNA are used as loading controls). B. 
Schematic representation of the alternative fates of linc-MD1: it can be cleaved 
by Drosha, producing two cut-pff products and a pre-miR-133b (left) or it can 
be exported to the cytoplasm as linc-MD1 (right). C. Western blot of HuR after 
HuR knock-down (Actinin as loading control, left) and RT-PCR for linc-MD1 in 
nuclear and cytoplasmic fractions, for its 5’ cut-off product and for miR-133b 
after HuR knock-down. Adapted from Legnini et al., 2014, reproduced under the 
license N° 3785820559384. 
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Figure 9 
 
Figure 9. Possible model for HuR and linc-MD1 activity during myoblast 
differentiation. HuR is activated after induction of differentiation and it sustains 
linc-MD1 synthesis, which in turn prevents HuR to be degraded by miR-133. 
MiR-133 accumulates and once it exceeds a certain threshold it triggers both 
HuR and linc-MD1 degradation. This provides a temporal window for miR-133 
activity, which is restricted to terminal differentiation. 
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2.4. Contradictions and possibilities arise from quantitative 
modelling of competition for microRNA binding. 
Besides our observations, several papers contributed to the 
formulation of the so-called ceRNA hypothesis (Tay et al., 2011, 
Karreth et al., 2011 and many others).  According to such model, 
competing endogenous RNAs, or ceRNAs, are transcripts that share 
multiple microRNAs binding sites that represent a sort of language 
through which ceRNAs can cross-talk one to each other. This 
means that a perturbation in a given ceRNA (e.g. transcriptional 
activation) is transferred to any other ceRNA that shares sufficient 
microRNA target sites, because of a change in the concentration of 
free-to-bind microRNAs. This hypothesis has been strongly 
criticised on the basis of quantitative assessments indicating that 
physiological concentrations of mRNAs and microRNAs within 
living cells are not compatible with ceRNA-like effects (Denzler et 
al., 2014). Specifically, titration of target abundance of miR-122 in 
hepatocytes and liver by overexpression produced a release of 
other targets repression in a threshold-like manner only after 
adding more than 1.5 x 105 additional target molecules per cell, a 
value that easily exceeds the quantity of any endogenous transcript.  
A few theoretical analyses tried to reconcile the experimental 
evidence of ceRNA-like effects with quantitative models 
describing the dynamics and steady state of a system comprised of 
N ceRNA molecules in competition for binding to a given 
microRNA (Figliuzzi et al., 2013 and 2014, Ala et al., 2013, Bosia 
et al., 2013 and Jens et al., 2015). A theoretical approach is 
necessary for defining the limits within a ceRNA effect is possible 
regardless the contingent experimental conditions that characterize 
laboratory manipulations (such as the concentration of a given 
microRNA and its targets). Therefore, it is possible to investigate 
the dependency on parameters of a simplified model, which may 
determine the ideal conditions required for observing ceRNA-like 
effects. A couple of studies (Figliuzzi et al., 2013 and 2014 and 
Bosia et al., 2013) faced the problem in depth and reported 
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convergent conclusions. First of all, it is predicted that competition 
can happen in a threshold-like manner, around a concentration of 
bound ceRNA approximately equal to half of the theoretical 
maximum, a regime that allows fast changes of ceRNA-microRNA 
complexes concentration in response to relatively small changes in 
free microRNA concentration. Second, such effect is observed at 
steady state only when introducing a stoichiometric component of 
the decay of ceRNA-microRNA complexes. This means that the 
rate of ceRNA-microRNA complex decay is nonzero or, in other 
words, that when a microRNA binds to its target they can be 
degraded together. It is not easy to predict a biological meaning for 
such parameter, but not impossible: one may suggest that a reliable 
ceRNA effect can be observed after sequestration of microRNA-
target complexes in P-bodies or other stable foci able to bring the 
microRNA irreversibly out of solution. On the other hand, target-
mediated degradation of microRNAs has been also observed, but 
only in specific and limited cases (Ameres et al., 2010 and Cazalla 
et al., 2010). Another important aspect emerging from those 
quantitative studies is that strong and specific ceRNA effects can 
be detected out of equilibrium. This means that after inducing a 
perturbation in the system, e.g. a change in the transcription rate of 
a ceRNA, an effect on the levels of other ceRNAs is observed also 
in the absence of stoichiometric decay but only before a full steady 
state relaxation. It therefore seems that a fully competitive system 
cannot account for ceRNA cross-talk, which instead can take place 
in a subset of specific conditions (stoichiometric decay, non 
equilibrium). The reasons why such conditions are not likely to 
exist in average biological systems are fully described in Jens et al. 
(2015), where the authors used a simpler but elegant model for 
predicting the impact of a perturbation in a microRNA target on 
the occupancy of the rest of its binding sites. Such model is based 
on the assumption that steady state is a good approximation of 
biologically meaningful scenarios and it results in the observation 
that ceRNA-like effects are achievable only when the amount of 
target sites added to the system is overwhelmingly high compared 
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to that of average mRNAs (roughly equal to the sum of all 
endogenous targets of the microRNA). It has to be said that both 
this study and the previous ones rely on parameters that are either 
estimated or measured in vitro. As an example, the number of total 
binding sites of a given microRNA (on which ceRNA-like effects 
strongly depend) can be predicted computationally or estimated 
through CLIP-based experiments, which anyway provide 
qualitative information on a bulk and not on single cells. On the 
other hand, the impact of dynamic changes in gene expression 
might be more important than thought, since many differentiation 
processes (e.g. myogenesis and linc-MD1 activation) proceed 
through fast and robust changes in the transcriptome of a cell 
population. In a similar scenario, a non-equilibrium effect might 
play a critical role that could be even resilient to approaching the 
steady state if feedback loops are taken into account (e.g. a sudden 
change in the concentration of a transcription factor may have 
strong and stable effects, regardless the transient nature of the up-
regulation of its mRNA).  
Regarding linc-MD1, I performed quantitative assessments of its 
concentration and of miR-133 and miR-135 concentrations and 
found interesting results (unpublished data). When inducing 
differentiation of C2C12 myoblasts, linc-MD1 abundance turns 
from roughly 0 to 103 molecules per cell, while miR-135 (linc-
MD1 has two binding sites for it) is present in circa 1.5 x 103 
molecules per cell and miR-133 in 5 x 103 molecules per cell. Such 
quantities, although do not fit with a simple ceRNA-like effect, are 
indicative of a possible decoy mechanism in particular conditions 
(e.g. transient effect or local effect), as suggested by experiments 
in Cesana et al. (2011) and Legnini et al. (2014).  
Finally, an important feature of the ceRNA hypothesis (that 
anyway does not apply to linc-MD1 and other cases) still waits to 
be tested: its dependency on the number and diversity of 
microRNA binding sites. Even in a steady state, non-stoichiometric 
scenario, an additive behaviour of several binding events of 
different microRNAs may contribute to detectable ceRNA effects. 
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To what extent such behaviour is possible depends on several 
factors, including the intrinsic nature of the microRNA degradation 
pathway, but also just simple quantitative parameters. Anyway, to 
study such possibility is beyond the aim of this work. 
In the end, it can be concluded that quantitative models do not 
support a generalized ceRNA theory, although they allow ceRNA 
effects in certain conditions. Nevertheless, some aspects of such 
models have to be faced more cautiously, and the biological 
relevance of transient effects, local concentrations and physical 
constraints to molecular diffusion should be more carefully taken 
into account when interpreting data on microRNA-target 
interactions. Conversely, when attributing an observed change in a 
given mRNA to a ceRNA effect, this has to be validated cautiously 
with quantitative approaches, and the dependency of such effect 
purely on microRNA binding has to be studied in detail. 
 
 
3. Circular RNAs are a new, large class of potentially 
functional molecules in Eukaryotes. 
 
3.1. High throughput total RNA sequencing and computational 
methods revealed an entire new class of RNA. 
In search of new potential actors in spatio-temporal regulation of 
myogenesis, we focused on a promising new class of RNAs: 
circular RNAs (circRNAs). In Eukaryotes, RNA molecules are 
normally linear polynucleotides which are necessary for the 
completion of the three main phases of the genetic information 
flow: bringing the coding information into the cytoplasm 
(mRNAs), converting it into proteins (rRNAs, tRNAs), and 
regulating the former two processes in time and space (miRNAs, 
lncRNAs etc.). Protein-coding genes and class II genes in general 
are typically transcribed into multi-exonic RNA species with 5' and 
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3' termini protected by a 5-methyl-guanosyne cap and a poly-
adenosine tail respectively. Although these two features provide 
mRNAs certain stability, coding transcripts typically have short 
half lives compared to other RNAs (e.g. ribosomal RNAs) or 
different biomolecules (e.g. proteins), and this is thought to be a 
key feature for achieving fast and robust regulation of gene 
expression.  
Recently, the availability of deep cDNA sequencing data obtained 
from ribosomal-depleted total RNA samples, combined with new 
computational approaches for aligning spliced sequencing reads, 
allowed the identification of several splicing products that were 
thought to be mistakes or unusual events before. Among them, an 
entire new class of RNA molecules lacking 5' and 3' termini have 
been discovered (Salzman et al., 2012, Jeck et al., 2013 and 
Memczak et al., 2013). According to such reports, the splicing 
apparatus can join a 5' splice site with the 3' splice site of an 
upstream intron, thereby producing a topologically closed RNA 
molecule, or circular RNA (figure 10). CircRNAs had been 
previously observed in a variety of model systems (Sanger et al., 
1976, Grabowski et al., 1981 and Danan et al., 2012), but the fact 
that these molecules are commonly produced by thousands of 
eukaryotic genes was ignored before the aforementioned studies. 
CircRNAs are capable of unprecedented stability due to the lack of 
5' and 3' ends, which are the substrates of the common system for 
RNA decay in Eukaryotes, exonucleases. Although this 
biochemical property, combined with other common RNA 
features, suggests a plethora of possible biological functions, it is 
still not clear whether they are capable of impacting biological 
processes. On the other hand, many efforts have been spent on 
dissecting the mechanism(s) of circRNA biosynthesis, showing 
that these molecules are broadly produced by the spliceosome in 
some specific contexts. 
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Figure 10 
 
Figure 10. Schematic representation of circular RNA production. A pre-mRNA 
comprised of N exons (here in blue, red and green) can produce a circular RNA 
from an internal exon (red) as consequence of a non-canonical splicing event, 
often driven by base pairing of the flanking introns. 
 
 
Ivano Legnini 
Pag 34  
3.2. Synthesis of circular RNAs is not (entirely) stochastic. 
In the aforementioned studies, thousands of circular RNAs have 
been detected from sequencing reads and their expression levels 
seem to shape in a random distribution with an impressive number 
of circRNAs with very low reads, in addition to an expected tail on 
the right of the curve representing a few, very highly expressed 
molecules. Although this might suggest a stochastic model for 
circRNA production, circRNA expression profiles form different 
cell types, tissues and organisms, in addition to the active 
circularization mechanisms that will be discussed in the next 
paragraph, suggest that among a noisy background of randomly 
produced circRNAs, a population of evolutionary conserved and 
possibly functional molecules exists.  
A first hint comes from the observation that the major product of 
hundreds of genes that can produce alternatively a messenger RNA 
or a circular RNA is the second one (Salzman et al., 2012). 
Therefore, circularization might be a way of getting rid of a 
functional transcript in certain conditions, or also a way of 
producing a molecule that has a biological function per se. The 
idea of functional circular RNAs was confirmed for the first time 
by two studies (Memczak et al., 2013 and Hansen et al., 2013) 
reporting that the circRNA CDR1as (or CiRS-7) is able to function 
as a sponge for miR-7 in brain. This circular RNA cannot be 
targeted by Ago2-dependent decay because of the lack of 5’ and 3’ 
termini, therefore is a perfect microRNA decoy, being able to bind 
to miR-7 with its > 70 sites and block this microRNA until it gets 
degraded in other ways. This mechanism of action seems to be 
restricted to CDR1as and perhaps a few other circRNAs (Hansen et 
al., 2013, Guo et al., 2014), indicating that if other members of this 
class of molecules exert any function, this must be a different one. 
A remarkable observation comes from several reports describing 
the relative abundance of circRNAs in different tissues or cell 
states. Especially for neuronal differentiation and brain 
development, it has been shown that circRNA production can be 
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dramatically regulated (You et al., 2015, Rybak-Wolf et al., 2015 
and Venø et al., 2015). Circular RNA sub-cellular localization is 
also regulated, being known that they can be transported into the 
nucleus and that they can be extremely enriched at synapses 
(Hansen et al., 2011 and You et al., 2015). Dynamic expression, 
regulation, relative abundance, sequence and positional 
conservation (Memczak et al., 2013 and Rybak-Wolf et al., 2015) 
are important features that make us speculate that a subset of 
circRNAs may be indeed functional molecules, but, given the 
exception of few microRNA sponges, this has still to be proven. 
 
3.3. RNA circularization in Eukaryotes proceeds via a back-
splicing reaction. 
Circular RNAs made up of covalently closed exonic sequences in 
Eukaryotes were discovered more than 20 years ago (Nigro et al. 
1991, Capel et al. 1993; Cocquerelle et al. 1993 and Zaphiropoulos 
1997), and their synthesis was ascribed to the splicing machinery, 
that could join the splicing donor of an intron to the acceptor of 
another intron upstream in the pre-mRNA, a phenomenon that was 
considered a mistake by many (mis-splicing, exon shuffling, exon 
scrambling).  
When those molecules were recently re-discovered, the first 
question that people in the field tried to address was about their 
biosynthesis. The first information we had was that exon 
circularization or back-splicing was more likely to happen in the 
presence of very long introns and was associated to the occurrence 
of Alu repeats in the flanking intronic sequences (Jeck et al., 2013). 
Such observation was confirmed and extended by others: while 
human cells have Alus, in mice and other species circular RNA 
production is associated to repetitive elements with a different 
origin (Liang et al., 2014, Zhang et al., 2014 and Ivanov et al., 
2015). The use of minigenes carrying exons that are naturally 
circularized with different portions of their flanking introns 
revealed that most of the information needed for back-splicing is 
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contained in introns (Ashwal-Fluss et al., 2014). Therefore, 
circularization occurs via base-pairing of short sequences 
embedded in intronic regions, thus bringing in physical proximity 
the donor and acceptor sites that will be joined to form a circRNA. 
This is confirmed by the high efficiency of circRNA 
overexpression obtained with plasmids where the upstream 
intronic region of a given circRNA is inverted and cloned again 
downstream to it (Hansen et al., 2013). Also A-to-I RNA editing 
can play a role in the process, as ADAR1 was shown to inhibit 
circularization by blocking base pairing of Alu elements through 
its catalytic activity (Ivanov et al., 2015). The whole process is 
thought to occur co-transcriptionally, as it was observed that 
circular RNAs are present in chromatin-bound nascent RNA in 
flies (Ashwal-Fluss et al., 2014). On the other hand, in human 
cells, circularization can be linked to 3’ end formation, as the 
presence of any kind of terminator is required for efficient back-
splicing (Liang et al., 2014 and Kramer et al., 2015). This seems to 
be dependent on the length of the flanking repetitive elements: 
when a couple of short inverted repeats is substituted with longer 
ones, indeed circularization happens also without a correct 3’ end 
formation in human cells (Kramer et al., 2015). This observation 
suggests that circularization can occur with different dynamics: 
strong base pairing can induce fast and efficient back-splicing, 
while circRNAs with a less affinity of the flanking introns may be 
produced through a slower reaction, possibly favoured by 
additional factors. This is also strongly suggested by the 
observation that back-splicing happens also in S. Pombe, where 
repetitive elements are absent and the back-splicing reaction 
proceeds via an intermediate made of an exon-containing lariat 
(Barrett et al., 2015). Being known that the canonical splicing 
machinery is responsible for back-splicing (Starke et al., 2015), 
additional elements that may contribute to circularization are 
obviously RNA binding proteins (RBPs). The first one that has 
been identified is Muscleblind, that it is able to control its own 
concentration by inducing circularization of the second exon in its 
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pre-mRNA (and also other pre-mRNAs, Ashwal-Fluss et al., 
2014). More recently, an RNAi-based sceening of RNA binding 
proteins modulated during epithelial-to-mesenchimal transition 
identified Quaking as the responsible factor of the global increase 
of circRNA production during such process (Conn et al., 2015). In 
both cases the direct binding of the RBP is required for 
circularization, suggesting the idea that this binding may facilitate 
base pairing of the flanking introns or bring the splice sites in close 
proximity as result of protein oligomerization. In general, RBPs, 
SR proteins and hnRNPs seem to play a role in circularization 
(Kramer et al., 2015), again indicating that such process may be 
not simply a splicing mistake, but a way of regulating gene 
expression or even producing functional molecules. 
 
Ivano Legnini 
Pag 38  
Aim of the thesis 
 
 
While concluding my work on linc-MD1 and post-transcriptional 
control of myogenesis, the field of circular RNAs exploded with 
unprecedented and fascinating findings. Although it seemed clear 
that something important resided behind the broad production of 
those new molecules, most of the focus was directed towards the 
understanding of their synthesis, and not their function. This was 
mostly due to the fact that circular RNAs are a family of 
biochemically-related molecules and apparently not a functional 
class. Therefore, understanding their role in biological phenomena, 
if there’s any, is extremely challenging. One finding came with the 
characterization of CDR1as/CiRS-7 as a microRNA decoy, but it 
was clear at the time that such mechanism of action was an 
exception and not the rule. Although the biochemical features of 
circular RNAs, especially their exceptional stability, suggest a 
myriad of captivating biological functions, we still don’t have a 
clue about their evolutionary meaning. The study of muscle 
differentiation has been a powerful source of paradigms in 
molecular biology, especially in the field of non-coding RNA. The 
molecular mechanisms that trigger cell differentiation are clear and 
the ability to reproduce such process in vitro with cells coming 
from different species is a potent tool for studying gene functions 
from an evolutionary point of view. Moreover, the transition from 
proliferating myoblasts to differentiated myotubes through a series 
of distinct and recognizable stages enables to infer possible 
functions from gene expression patterns (e.g. a gene activated 
during terminal differentiation is more likely to play a role in 
mature myotubes rather than in proliferating cells). We therefore 
decided to approach the circular RNA field and try to understand if 
these molecules are capable of biological function in myogenesis. 
The idea was to analyse circRNA expression dynamics in both 
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human and murine myoblasts differentiation, then select a subset 
of highly expressed, regulated and conserved molecules, knock 
them down and screen for phenotypes associated to their down-
regulation. After identifying circRNA-associated phenotypes, we 
wanted to understand possible general mechanisms of action, 
focusing on one main candidate that will be described in the 
following section. All the steps that I just mentioned were almost 
completely unexplored at the time this work was started, we 
therefore had to invent and set up most of the computational and 
experimental procedures that will be described in the next chapters. 
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Results and Discussion 
 
 
Note: some of the results and figures included in this section are 
part of a manuscript submitted for publication. In case of 
acceptance, all the publication rights will be ceased to the journal 
publisher, regardless the timing of publication of this thesis. 
 
1. CircRNAs expression dynamics in myogenesis. 
 
1.1. CircRNAs are abundant, conserved and highly expressed. 
With the aim of identifying circular RNAs expressed during 
muscle differentiation, we collected total RNA from 2 biological 
replicates of human (9208) and mouse (C2C12) myoblasts cultured 
in growth medium (GM) or induced to differentiate into myotubes 
(DM). We performed paired-end ribominus RNA sequencing and 
adapted the FindCirc computational pipeline (Memczak et al., 
2013) in order to detect back-splicing events. We first processed 
RNAseq data for gene expression analysis: we mapped reads with 
TopHat and reconstituted the transcriptome with Cufflinks (data 
summarizes in table 1). Differential gene expression analysis was 
performed in order to check the quality of the in vitro 
differentiation experiments. While FPKM of genes in technical 
replicates were almost perfectly correlated (> 98% Pearson 
correlation, figure 11, upper panels), gene expression in myotubes 
compared to myoblasts was highly diverse with > 3000 genes 
significantly up-regulated or down-regulated in one of the two 
conditions, in both human and mouse systems (figure 11, lower 
panels). When looking at the enrichment of gene products up-
regulated in myotubes versus myoblasts, in terms of gene ontology 
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(GO) biological process keywords, we found a consistent and 
significant enrichment for genes related to muscle differentiation 
and function (figure 12). Moreover, we assessed the expression of 
well-known specific markers of muscle differentiation (MyoD, 
Myosin Heavy Chain, Muscle Creatine Kinase and Dystrophin) by 
qRT-PCR, which confirmed the data obtained by RNAseq (figure 
13). At this point we focused on circular RNAs, which can be 
identified through reads spanning the so-called head-to-tail splice 
junctions resulting from back-splicing events. RNAseq reads were 
re-aligned to the reference genomes, the ones contiguously aligned 
were discarded and the remaining reads were used as input for 
FindCirc (figure 14A). Among the thousands of such events that 
we identified, we applied some filters (> 2 unique reads spanning 
the splice junction, high quality mapping and low distance between 
donor and acceptor sites) for discarding possible artefacts. As 
described in figure 14B, thousands of bona fide circular splicing 
events were found in both human and mouse samples, many of 
which expressed at low levels, with a tail on the right of the 
distribution constituted by a fraction of a few highly expressed 
molecules (figure 15). Almost 90% of them derive from internal 
exons of protein coding genes, while a few are expressed from 
non-coding genes or intergenic regions, possibly due to their 
average lower expression level (figure 14C). Almost 10% of 
circRNAs were expressed at similar or higher levels with respect to 
the linear counterpart (by comparing the number of reads mapping 
on circular versus linear splice junctions). Interestingly, we found 
more than 500 positionally conserved circRNAs between human 
and mouse (figure 14D). Our criterion for conservation required 
the genomic location in human to overlap with the synthenic 
region in mouse. Considering that low abundance species might 
have been missed by this analysis, the actual number of conserved 
circRNAs may be even higher, as also indicated by the observation 
of a similar overlap between two replicates of the same sample.  
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Table 1 
 
9808 (Human) Genes 
 
GM DM 
FPKM>1 15004 15488 
FPKM>10 6032 6009 
FPKM>100 803 732 
Diff. Expr. 3686 3303 
FC>10 258 333 
   
C2C12 (Mouse) Genes 
 
GM DM 
FPKM>1 12682 13019 
FPKM>10 6244 6365 
FPKM>100 907 879 
Diff. Expr. 3848 3975 
FC>10 359 404 
   
Table1. Summary of gene expression analysis performed with TopHat/ Cufflinks/ 
Cuffdiff. Genes expressed with more than 1, 10 and 100 FPKM are shown, 
together with the number of differentially expressed in GM versus DM and 
among them the ones with a fold change > 10. 
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Figure 11 
Figure 11. Scatter plots for biological replicates of FPKM of genes in human 
(left) and mouse (right) for GM (up) and DM (middle) samples. On the bottom 
are shown scatterplots for mean FPKM in GM versus DM. In red are 
highlighted genes differentially expressed according to Cuffdiff. Straight lines 
delimiting genes with a fold change > 10 and > 100 are drawn in black. 
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Figure 12 
	  Figure 12. Wordcloud of Gene Onthology biology process keywords for genes 
differentially expressed in DM versus GM for human (left) and mouse (right). 
The dimensions of the words correlate with their enrichment. 
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Figure 13 
Figure 13. qRT-PCR validation of known markers of muscle differentiation 
(dystrophin or DMD, myosin or MYH2, Creatine Kinase or CKM, MyoD) in 
human (up) and mouse cells (down) in GM and DM. The expression level 
measured by qRT-PCR (black) is shown together with the FPKM (red). 
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Figure 14 
 
 
Figure 14. Identification of circRNAs in mammalian myoblast differentiation. A. 
Experimental and computational pipelines for identification of circRNAs from 
human and mouse myoblasts (expressing MyoD and Myf5) and myotubes 
(expressing Myosin Heavy Chain, MHC and Creatin Kinase Muscle, CKM). B. 
Number of detected linear and circular splicing events per sample together with 
bona fide circRNAs passing selection filters. Samples are human (9208) and 
mouse (C2C12) myoblasts (GM) and myotubes (DM) in two replicates (#A and 
#B). C. Left panel: genomic annotation of circRNAs. Right panel: structural 
annotation of circRNAs mapping to coding regions. D. Overlap of unique 
circRNAs in human and mouse samples. 
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Figure 15 
Figure 15. Histogram showing the number of circRNAs detected in relation with 
the number of unique reads spanning the head-to-tail junction (only human 
samples are shown). 
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1.2. CircRNA expression is modulated in muscle differentiation 
and disease. 
In order to perform quantitative analyses on circRNA expression 
and regulation, we took human samples and further reduced our list 
to a set of highly expressed molecules by requiring at least 5 
unique reads mapping to the head-to-tail junction in at least one 
sample. With this threshold, while the technical replicates had an 
overall good correlation (Fig. 16), the comparison between 
myoblasts and myotubes revealed a global change in circRNA 
expression (~45% circRNAs having at least 2-fold variation in one 
of the two conditions, figure 17), meaning that the expression of 
these molecules is actively modulated in response to cell 
differentiation. We also analysed RNAseq data from human 
myoblasts derived from Duchenne Muscular Dystrophy (DMD) 
patients and found substantial changes of circRNA expression with 
respect to normal myoblasts. Hierarchical clustering analysis of 
normal and dystrophic myoblasts and myotubes revealed that 
indeed DMD cells have a unique signature in terms of circRNA 
expression levels (figure 17): specific subsets of transcripts were 
differently abundant in DMD with respect to controls both in GM 
and in DM conditions. This is in line with the notion that DMD 
cultured cells have a slower progression into the differentiation 
process: they have a higher proportion of non-fusing myoblasts, 
fusion itself is delayed and differentiation markers are down-
regulated (Delaporte et al., 1984, Cacchiarelli et al., 2010 and 
Cazzella et al., 2012). Notably, circRNA abundance tends in 
general to increase during differentiation (figure 14), as has been 
described for neuronal differentiation and in epithelial-to-
mesenchimal transition.  The circular/linear ratio also followed this 
trend (figure 18). This is possibly related to the high stability of 
these molecules: during differentiation, induction of circRNAs at 
the transcriptional level, combined with a slow turnover, could lead 
to their accumulation over time. This fact has been also observed 
in vivo (Westholm et al., 2014) and might represent an important 
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feature of circRNAs, as they could be involved in ageing-related 
phenomena or in epigenetic inheritance. 
We then tried to address the question of whether modulation of 
circRNAs expression in myogenesis was due to transcriptional 
regulation of their host genes or to post-transcriptional events, such 
as competitive biogenesis between the linear and the circular 
isoforms within the same gene. Therefore, we analysed the 
relationship between the fold change ratios of circular versus linear 
expression level in GM versus DM and found a positive correlation 
(figure 18C). Additionally, the abundance of circRNAs produced 
from up-regulated, stable or down-regulated genes, according to 
FPKMs calculated with Cuffdiff, indicated that the induction of 
circRNAs coming from up-regulated genes is significantly higher 
than that of stably expressed genes, which in turn is higher than 
that of down-regulated genes (Fig. 2F). However, exceptions to 
this trend were detected, such as the BNC2 gene that in growth 
conditions produces mainly the linear mRNA, while in 
differentiated cells the circRNA. In figure 19 the BNC2 locus 
coverage and circRNA abundance are shown together to those of 
circ-CDYL, which represents a paradigm of the most common 
scenario of (possibly) transcriptional activation of a locus followed 
by accumulation of an embedded circRNA. BNC2 and circ-BNC2 
expression pattern is conserved in mouse differentiation and may 
represent an interesting fact, which will be discussed more in detail 
in the next section.  
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Figure 16 
Figure 16. Correlation of circRNA reads in replicates. Scatterplots showing 
reads mapping to highly expressed circRNA junctions in two myoblast replicates 
(GM, #A and #B, left) and myotube replicates (DM, #A and #B, right). 
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Figure 17 
 
Figure 17. Heat map showing selected circRNA expression levels in WT and 
DMD myoblasts (GM, #A and #B) and myotubes (DM, #A and #B). Values are 
normalized as row Z-scores. 
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Figure 18 
 
Figure 18. A. Scatterplot showing circular/linear (“C/L”) ratio in GM versus 
DM, calculated as log2 of the number of reads mapping to a circular junction 
divided by the mean of reads mapping linearly at the same genomic coordinates. 
B. Histogram of C/L ratio: in blue distribution in GM, in red in DM. C. 
Scatterplot of fold change of reads mapping to circRNA junctions versus reads 
mapping to linear junctions at the same coordinates. Linear regression is shown 
in red. Black lines correspond to a fold change of 2. D. Bar plot representing 
fold change of circRNA expression in myotubes versus myoblasts (DM/GM) 
grouped by differential expression of host gene according to Cuffdiff FPKMs. 
“Up” are up-regulated genes, “Eq” are non differentially expressed genes, 
“Down” are down-regulated genes (fold change > 2). Three asterisks indicate a 
Wilcoxon-Mann-Whitney test-derived p-value below 0.01. 
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Figure 19 
Figure 19. Left panels: Coverage plot of genomic loci of circ-BNC2 and circ-
CDYL. Right panels: bar plot showing reads mapping to circular (Circ) and 
linear (Lin) splice sites for circ-BNC2 and circ-CDYL in GM (blue bars) and 
DM (red bars). 
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2. CircRNAs are functional. 
 
2.1. Experimental validation of circular RNAs. 
At this point, we wanted to understand if circular RNAs could 
impact on the process of myoblast differentiation. We therefore 
selected specific criteria in order to restrict the number of 
candidates for further characterization: I) conservation, II) 
expression level, III) differential expression upon differentiation, 
and IV) circular/linear ratio. This filtering yielded 31 circRNAs, 
which are shown in table 2. We proceeded with experimental 
validation of the selected candidates in order to confirm their 
expression, and we decided to use RT-PCR and RNase R 
treatment. By using a couple of divergent primers in the PCR 
reaction, we could obtain an amplification signal only in case of a 
truly circular RNA. Moreover, the presence of concatemers 
generated by rolling-circle retro-transcription would confirm such 
conformational status. We therefore designed a couple of divergent 
primers for all the 31 candidates, accompanied by a third primer in 
an external exon for amplifying the corresponding linear mRNA. 
As summarized in table 2 (full results in figures 20 and 21), out of 
31 candidates, only one, circ-MYL4, was not detected as a band of 
the expected size in human samples. Circ-TTTY16 was instead not 
detected in mouse samples, because it is located in the Y 
chromosome that is not present in C2C12 cells. Almost all 
circRNAs showed, besides the predominant band of the expected 
size, additional slower migrating bands, probably corresponding to 
concatemers generated by rolling circle retro-transcription. We 
cloned and sequenced the amplicons and those concatemers for a 
subset of circRNAs (figure 22), confirming our hypothesis. As a 
second important validation test, we used RNase R treatment of 
total RNA samples. RNase R is an exonuclease able to degrade 
linear RNA molecules but not circular ones (Suzuki, 2010). Out of 
30 putative circRNAs, 29 were confirmed as non-accessible to the 
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exonuclease. Only one, circ-NEB, was digested by RNaseR as 
efficiently as its linear counterpart (summarized in table 2, full 
results in figures 23 and 24). Circ-NEB is predicted to come from 
the Nebulin gene, which contains dozens of repetitive exons and it 
is highly expressed in muscle tissues. To less extent, this is true 
also for MYL4. Mapping of sequencing error-containing reads can 
easily result in the annotation of false circular RNAs. In our case, 
RT-PCR and RNase R resistance revealed those false positives, 
returning a list of 29 bona fide conserved circular RNAs.  
We then performed nuclear/cytoplasmic fractionation of human 
and mouse cells in order to obtain a hint on circRNA biogenesis 
and localization. Results indicated that all circular species were 
almost exclusively located in the cytoplasm both in mouse and 
human cells (figures 25 and 26). This was already observed in a 
few other studies and constitutes an intriguing fact: although the 
Exon Junction Complex (EJC, which is presumably deposited on 
circRNAs) is known to play a role in RNA export, it is known that 
besides specific exportins (e.g. Exp-t and Exp-5 for tRNAs and pri-
microRNAs respectively), nuclear export depends on the presence 
of 5m-guanosyne cap- and polyA-binding proteins. We can 
imagine a cap-independent mechanism of circular RNA export 
depending on specific structural motifs, which anyway have not 
been identified so far, or we also can hypothesize a non-active 
mechanism of slow accumulation of circRNAs in the cytoplasm as 
a consequence of mitotic nuclear envelope break down. Such 
hypothesis could be easily tested in non-dividing cells, were 
circular RNA synthesis should be followed by nuclear 
accumulation.  
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Table 2 
(continues on next page) 
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Table 2  
(continues from previous page) 
Table 2. List of the selected 31 circular RNAs and summary of their 
experimental validation. Columns contain: gene name, genomic coordinates 
(hg19 for human, mm10 for mouse) of the head-to-tail splice junction, unique 
reads mapped to the splice junction in GM#A, GM#B, DM#A and DM#B, RT-
PCR validation (yes if the expected band was obtained, no if not), RNase R 
resistance (yes if the recovery after RNase R treatment of the circular was 
higher than for the linear, no if not) and localization (cyt for cyoplasm).
Ivano Legnini 
Pag 58  
Figure 20 
Figure 20. RT-PCR validation of human circRNAs. CircRNAs and the 
corresponding linear transcripts were amplified from cDNA obtained from 
myoblasts (GM) and myotubes (DM) in biological duplicates with divergent and 
convergent primers 
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Figure 21 
Figure 21. RT-PCR validation of mouse circRNAs. CircRNAs and the 
corresponding linear transcripts were amplified from cDNA obtained from 
myoblasts (GM) and myotubes (DM) in biological duplicates with divergent and 
convergent primers. 
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Figure 22 
Figure 22. A. Schematic representation of the amplicons obtained by RT-PCR 
on circular RNAs. B. Electropherograms showing the Sanger sequencing results 
of the head-to-tail junction present in the amplicons obtained by RT-PCR for 
circ-CDYL, QKI and ZNF609. 
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Figure 23 
 
Figure 23. RNase R validation of human circRNAs. CircRNAs that were 
amplified by qRT-PCR from cDNA prepared from RNA treated or non treated 
with RNase R, together with their corresponding linear RNAs. The ratio of 
treated versus non-treated, of circRNA versus corresponding linear RNAs, was 
tested by two tailed Student’s t test. Red bars: RNase R +; Blue bars: RNase R -. 
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Figure 24 
 
Figure 24. RNase R validation of mouse circRNAs. CircRNAs that were 
amplified by qRT-PCR from cDNA prepared from RNA treated or non treated 
with RNase R, together with their corresponding linear RNAs. The ratio of 
treated versus non-treated, of circRNA versus corresponding linear RNAs, was 
tested by two tailed Student’s t test. Red bars: RNase R +; Blue bars: RNase R -.  
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Figure 25 
 
Figure 25. Human circRNAs that passed the previous validation steps were 
screened for subcellular localization by RT-PCR amplification from cDNA 
obtained by retrotranscribing nuclear and cytoplasmic RNA separately. 
Fractionation was performed in duplicate. 
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Figure 26 
 
Figure 26. Mouse circRNAs that passed the previous validation steps were 
screened for subcellular localization by RT-PCR amplification from cDNA 
obtained by retrotranscribing nuclear and cytoplasmic RNA separately. 
Fractionation was performed in duplicate. 
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2.2. An RNAi-based functional screening reveals circular 
RNAs actively involved in myogenesis. 
At this point, having set a list of experimentally validated circular 
RNAs, all expressed at high levels and conserved between human 
and mouse myoblasts, we sought to understand whether among 
them there were any functional ones. Defining “functional” a 
certain molecule is trickier than one could expect. As a general rule 
of thumb, functionality in classical genetic studies was defined by 
the insurgence of a phenotype in association to a certain genotype. 
If such mutation was mapped in a gene, then that gene was thought 
to be responsible for the phenotype, it therefore had a “function”. 
With the advent of genetic engineering, a different definition of 
functionality arose. Overexpression and knock-down of gene 
products became possible and many studies focused on cellular or 
molecular phenotypes, namely quantitative or qualitative features 
of cultured cells or cellular extracts specifically achieved after the 
experimental perturbation (e.g. the proliferation rate or the 
transcriptome). The theoretical space of the possible phenotypes is 
then virtually infinite, as any feature observed in any model system 
after a perturbation in the concentration of a bio-molecule could be 
interpreted as sympthomatic of a “function”. To discuss the 
meaning of a phenotype observed in cell culture systems and its 
relationship with in vivo model systems is beyond the aim of this 
thesis. Anyway, I’ll use the word “phenotype” as indicative of 
“function” from the molecular point of view. The aim of this work, 
indeed, is mainly to understand if circular RNAs can impact 
biological processes, it doesn’t matter if in an artificial system or in 
living organisms. To do so, most of the focus is centred on the 
design and perfection of an experimental set up that is useful to 
univocally attribute a phenotype to the function of a given circular 
RNA, a task that is sufficiently difficult itself.  
The first issue to be solved was to define the phenotype to observe. 
Since the working hypothesis was that circular RNAs might be 
involved in myogenesis, we wanted to set a list of quantitative 
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parameters describing the “myogenic state” of cultured cells. We 
opted for leading an in vitro differentiation experiment of 
myoblasts after knock-down of each circRNA candidate, followed 
by fixation and staining of cells at two stages: I) after 48h of 
differentiation (72 post-knock-down) and II) after 96h of 
differentiation (120 post-knock-down). At those time points, we 
stained cells by immunofluorescence for Myogenin (Myog), a 
marker of early differentiation, and Myosin Heavy Chain (MHC), 
a marker of terminal differentiation, in addition to nuclear DAPI 
staining (set-up experiment shown in figure 27). We performed the 
experiment in a 96-well format in triplicate and took a picture of 
each treatment with a 4X objective in an automatized system for 
capturing an area corresponding to almost the entire well. We 
ended up with a total of more than 200 pictures in 3 channels 
(Myog/MHC, DAPI, DIC) that were then analysed with a script 
that we wrote especially for this aim. We included the definition of 
a set of parameters used for quantitate the “myogenic state” of the 
treated cells. First of all, for cells at 48h of differentiation, we 
measured the total number of cells, the fraction of Myog-positive 
cells and the intensity of the Myog signal. For cells at 96h of 
differentiation, we measured the number of nuclei, the Fusion 
Index (number of nuclei embedded in multi-nucleated fibers / total 
number of nuclei), the average number of nuclei per fiber, the 
Maturation Index, that we defined as the number of nuclei 
embedded in multi-nucleated fibers / the nuclei in MHC-positive 
cells, the dimensions of MHC-positive cells and MHC-positive 
fibers, the fraction of MHC-positive nuclei and the fraction of 
MHC-positive fibers. All those parameters are indicative of the 
differentiation state of the cells and not necessarily correlated, 
providing enough information to detect substantial changes in the 
differentiation process in response to knock-down experiments. 
The quantity of such parameters was then called a “phenotype” if 
statistically significant as defined by Students t-test calculation 
followed by Bonferroni correction with a 0.1 null-hypothesis 
rejection threshold for each triplicate with respect to the bulk of the 
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experiment. The sum of significant parameters for each treatment 
contributed to the estimate of the intensity of the phenotype, 
therefore providing a tool for choosing a few candidates to further 
characterize. In addition to this analysis of differentiation, we 
decided to chose a subset of circRNAs that were highly expressed 
in proliferating cells for an additional phenotype screening: 
following knock-down, we replaced the culture medium with 
bromodeoxyuridine (BrdU)-containing medium, which is used for 
labeling of the replicating DNA with BrdU-specific antibodies, 
therefore allowing to monitor the proliferation rate of the cells. 
A second, important issue to solve was how to achieve efficient 
and specific circular RNA knock-down. The molecular tool that we 
decided to use is RNA interference, as it is fast, cheap and usually 
efficient. SiRNAs had never been used for circular RNAs, we 
therefore had to design an appropriate strategy, including the 
sequence specificity, the chemistry, the delivery. To achieve 
circRNA-specific knock-down, one has to consider that circular 
RNAs usually (in our case, always) are produced from loci that 
also make linear transcripts containing the same sequence of the 
circle. Therefore, the only sequence that is really specific for the 
circRNA product is the head-to-tail junction, where we decided to 
design our siRNAs. Moreover, siRNAs can work as microRNAs if 
targeting with their seed sequence any given RNA, therefore they 
have to be designed in a way that excludes off- targets. The most 
obvious off-targets are the linear counterparts of circular RNAs, 
since part of the head-to-tail junction is embedded in their linear 
sequence. Where possible (overcoming technical restrictions to 
siRNA design), we opted for positioning the seed sequence on the 
head-to-tail junction. Since this wasn’t always achievable, the 
chemistry of siRNAs was changed, including a patent-protected 
modification (On-target plus, Dharmacon) in the seed sequence 
that prevents microRNA-like effects when the siRNA binds only 
with its seed, without extensive 3’ complementarity. To further 
reduce the risk of off-targeting effects and to increase the chance to 
obtain efficient knock-down, we tried to design two different 
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siRNAs for each target. Following these rules, it was possible to 
design two siRNAs for 20 circRNAs, one for 5 circRNAs and none 
for the 4 remaining ones (see list of siRNAs in Materials and 
Methods).  
Regarding the delivery of siRNAs, we had first to decide for an 
appropriate cell line, and subsequently set up the optimal 
experimental procedures. We decided to use human primary 
myoblasts (9208, Telethon Biobank), because they resemble 
molecular and morphological features of myogenesis better than 
commercial cell lines and are relatively easy to culture and 
differentiate in vitro (figure 2 and 27). Due to their poor 
transfectability, we tried several concentrations of different 
liposome-based reagents and developed a reverse transfection 
protocol that allows high transfection efficiency of siRNAs in 
these cells (see Materials and Methods). 
Having set up the whole experiment, we proceeded with 
transfection, differentiation and analysis of the high-content 
genomic screen (figure 28). From the same samples, the relative 
abundance of the circular versus linear form was tested in order to 
confirm the specific down-regulation of the circRNA. This 
revealed that at least one siRNA for 17 different genes specifically 
down-regulated the circular form without affecting the linear 
mRNA (figure 29).  
As depicted in figure 30, many phenotypes were associated to the 
circRNAs knock-down. Among them, we focused on two species 
(circ-QKI and circ-BNC2) that displayed strong altered and 
opposite effects (representative images in figure 31). Of the two 
siRNAs used for circ-QKI, only one was specific for the circ-RNA 
(siRNA QKI#1), while the second induced a strong repression also 
of the linear mRNA (figure 32A). Both siRNAs inhibited 
differentiation, thus indicating that both circular and linear species 
may cooperate in the same biological process (figure 30). As an 
additional control, we used siRNAs that specifically target QKI 
mRNA and repeated our morphological analysis together with new 
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circ-QKI knock-down experiments (figure 32B). The phenotype 
associated to the circular RNA knock-down was confirmed and a 
similar phenotype was associated with the mRNA knock-down 
(figure 32B). Western blot for Myosin Heavy Chain confirmed 
these results, suggesting that both circ-QKI and QKI mRNA are 
required for proper differentiation of human myoblasts (figure 
32C). Of the two siRNAs used for circ-BNC2, one strongly 
repressed the circRNA and had a mild effect on BNC2 mRNA 
(siRNA circ-BNC2#1), while another resulted in poor knock-down 
of the circRNA (figure 32A). We focused on the first siRNA and, 
again, compared its effect on the myogenic phenotype and by 
Western Blot to the result of specific BNC2 mRNA knock-down 
(figure 32B and C). In this case, mRNA down-regulation produced 
a stronger pro-myogenic phenotype, indicating one of two 
alternative scenarios: a) as for circ-QKI and QKI mRNA, the 
effects of circular and linear RNAs are cooperative or b) the effect 
on differentiation observed in both cases is due BNC2 mRNA 
knock-down and not to circ-BNC2. This second scenario is also 
intriguing, given the fact that the BNC2 locus produces 
alternatively the linear mRNA in myoblasts and the circular RNA 
in differentiated myotubes (figure 19). Therefore, circularization of 
exon 6 of the BNC2 pre-mRNA mediated by some specific factor 
might be a way of getting rid of the anti-myogenic BNC2 mRNA 
when differentiation is stimulated. 
Lastly, both circ-QKI and circ-BNC2, up-regulated during in vitro 
differentiation of control myoblasts, are down-regulated in DMD 
conditions (figure 33); this compares well to the notion that 
dystrophic cells have a much slower progression into the 
differentiation process and confirms that those two genes might 
play a role in correct myogenesis. 
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Figure 27 
Figure 27. Immunofluorescence analysis of Myogenin and Myosin Heavy Chain 
(MHC) during differentiation of human primary myoblasts (from 24h to 120h 
post-differentiation). DAPI staining is shown next to each picture. 
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Figure 28 
Figure 28. Schematic representation of the RNAi screening setup. Myoblasts are 
cultured for 24 hours after reverse transfection of siRNAs, then switch to 
differentiation medium and fixed for Myogenin and MHC immunofluorescence 
after 48 and 96 hours of differentiation. 
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Figure 29 
Figure 29. Knock-down efficiency of circRNAs and linear mRNAs for each 
siRNA, as measured in the high-throughput screening pilot experiment. All 
circRNAs/linear mRNAs level in control scramble siRNA (si-ctr) are set at 1. 
RNA levels in siRNA-treated cells are shown as fold change with respect to 
control and normalized to HPRT mRNA, measured by qRT-PCR. Levels of 
circRNA and linear mRNA are shown in red and blue, respectively. 
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Figure 30 
Figure 30. Heat map showing the analysed “phenotypes” in color scale after Z-
score normalization. High values are shown in blue, while low values in red. 
Each column indicates one phenotype, each row one sample. The number of 
detected significant phenotypes is shown in red scale on the right. 
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Figure 31 
 
Figure 31. Human primary myoblasts were treated with either a control 
scramble siRNA (si-SCR) or with siRNAs against circ-QKI (si-QKI, oligo #1) 
and circ-BNC2 (si-BNC2, oligo #1) and induced to differentiate for 48 and 96 h. 
A representative immunofluorescence for MYOG and MHC together with DAPI 
staining is shown. 
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Figure 32 
Figure 32. A. Knock-down of QKI and BNC2 circular and linear isoforms with 
the indicated siRNAs. Dark grey bars represent RNA level in negative control 
(si-CTR) and are set at 1. Light grey bars represent RNA level after siRNA 
treatment. All RNA levels were measured by qRT-PCR in two independent 
experiments and normalized to Hprt mRNA. B. Heat map showing selected 
“phenotypes” in color scale after Z-score normalization. High values are shown 
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in blue, while low values in red. Each column indicates one phenotype, each row 
one sample, indicated on the right. The number of detected significant 
phenotypes is shown in red scale on the left. C. Western blot analysis of Myosin 
Heavy Chain (MHC) and GAPDH after knock-down of QKI (upper panel) and 
BNC2 (lower panel) circRNA and mRNA. A representative blot is shown on top 
of densitometric measurement of MHC/GAPDH in two independent experiments. 
 
 
Figure 33 
Figure 33. RNA levels measured by qRT-PCR of circ-QKI and circ-BNC2 in 
human wild type (WT) and Duchenne (DMD) differentiated cells. RNA 
measurements were performed from biological duplicates of 1 WT cell line (light 
grey bars) and 2 DMD cell lines (dark grey bars). 
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2.3. Circ-ZNF609 regulates myoblasts proliferation. 
As previously introduced, to investigate the role of circRNAs in 
myoblasts proliferation, we performed an independent analysis 
using bromodeoxyuridine (BrdU) labeling of nascent DNA (figure 
34). Among the circRNAs tested, we found that circ-ZNF609 
knockdown strongly reduced BrdU incorporation, suggesting that 
it is required for myoblast proliferation. This initial screening was 
validated by adding 3 new biological replicates. The results 
showed that circ-ZNF609 down-regulation reduced BrdU 
incorporation by 70% (figure 35A). Moreover, markers of 
proliferation such as CCDN1 and CDC25 were also significantly 
reduced (figure 35B). Confirming the selectivity of the siRNA, 
circ-ZNF609 levels were reduced by 90% of the control 
conditions, whereas the linear form was completely unaffected 
(figure 35B). To further confirm the specificity of this phenotype, 
we proceeded with different approaches that may define a standard 
of circRNA functional studies. In addition to circRNA-specific 
siRNAs (in this case a single siRNA, because the second didn’t 
work), we used linear mRNA-specific siRNAs, we performed the 
experiment also in mouse myoblasts and we performed 
complementation experiments. Knock-down of the linear mRNA 
did not induce any change in BrdU incorporation, suggesting that 
the circRNA itself is responsible for the phenotype (figure 35C). 
Knock-down of the circRNA in mouse myoblasts achieved results 
similar to the human system, although at lesser extent (not shown). 
This was anyway expected because we used a murine cell line 
(C2C12) having a proliferation rate that exceeds the one of any 
primary cell culture system, possibly due to mutations in the cell 
division control pathway. Lastly, and most importantly, the 
proliferation phenotype due to the knock-down of circ-ZNF609 
was complemented by transfection of an in-vitro synthesized 
circRNA, confirming its specificity beyond reasonable doubts 
(figure 35D). 
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Notably, circ-ZNF609, which is down-regulated during 
myogenesis in control myoblasts, is instead found at elevated 
levels in DMD conditions (figure 36A). This is consistent with the 
delayed differentiation phenotype of dystrophic primary 
myoblasts, paralleled by persistence of a high proportion of 
proliferating, non-fusing, myoblasts. Moreover, consistently with 
circ-ZNF609 involvement in cell proliferation, this molecule is 
also up-regulated in cell lines derived from patients with 
Rhabdomyosarcoma, a rare tumour deriving from muscle 
progenitor cells (figure 36B). 
 
 
Figure 34 
Figure 34. BrdU incorporation screening. Primary myoblasts were treated with 
either a control scramble siRNA (si-SCR) or with siRNAs against the circRNAs 
indicated and maintained in growth conditions. Bar plots represent the 
percentage of BrdU positive cells.  The values derive from three biological 
independent experiments. 3 asterisks indicate a p-value < 0.01 estimated with 
Student’s T test between an individual triplicate and the bulk experiment. 
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Figure 35. 
Figure 35. circ-ZNF609 specifically controls myoblasts proliferation. A. Left 
panel: primary myoblasts were treated with either a control scramble siRNA (si-
SCR) or with siRNAs against circ-ZNF609 (si-circ-ZNF609, oligo #1) and 
maintained in growth conditions. A representative BrdU labeling assay is shown 
together with DAPI staining. Right panel: bar plot showing BrdU incorporation 
levels in cells treated as in the left panel (dark grey bars, si-SCR; light grey 
bars, si-circ-ZNF609). B. RNA quantification by qRT-PCR of circ-ZNF609 and 
ZNF609, CCND1 and CDC25 mRNAs upon siRNA transfection (dark grey bars, 
si-Scr; light grey bars, si-ZNF609). C. As panel B with the addition of a sample 
treated with siRNA for circ-ZNF609 plus complementation with synthetic circ-
ZNF609 (IVC, intermediate grey shadow). D. Same as panel B, but with 
interference of linear ZNF609 instead of the circular form (si-ZNF609 mRNA). 
The values derive from three biological independent experiments: 1 asterisk 
indicates a p-value < 0.05, 2 asterisks indicate a p-value < 0.02 and 3 asterisks 
a p-value < 0.01 measured with Student’s t test. 
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Figure 36 
Figure 36. circ-ZNF609 is mis-regulated in pathological conditions. A. qRT-
PCR level measured in WT and DMD cells measured by qRT-PCR (mean and 
standard deviation from biological duplicates). B. Preliminary results of circ-
ZNF609 in WT versus Rhabdomyosarcoma cell lines (RB) in GM and DM. 1 
asterisk indicate a p-value < 0.05, 2 asterisks indicate a p-value < 0.02 and 3 
asterisks a p-value < 0.01 measured with Student’s t test. 
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2.4. Biochemical analyses suggest protein-coding capacity of 
circ-ZNF609. 
Having univocally attributed a role in myoblast proliferation to 
circ-ZNF609, we sought to identify the molecular mechanism 
behind its function. One suggestion came from the analysis of its 
sequence and genomic position. It originates from the 
circularization of the second exon of the ZNF609 gene. 
Interestingly, a 753-nt open reading frame is present in circ-
ZNF609, spanning from the AUG of the host gene to a stop codon 
created three nucleotides after the splice junction (figure 37). 
Translation of natural circular RNA templates has been observed in 
Archea (Kjems et al., 1988), but never in Eukaryotes. On the other 
hand, the chance of circRNA coding potential is indicated by some 
observations of artificial circularized mRNAs being translated in 
cultured cells (Abe et al., 2015). In order to determine whether this 
ORF was indeed translated, we first used sucrose gradient 
fractionation of human cell lysates to test circ-ZNF609 association 
with polysomes. Figure 38 shows that a significant portion of circ-
ZNF609 sediments with heavy polysome fractions, while the rest 
remains in the non-bound fraction. The circular conformation of 
the polysome-bound circ-ZNF609 RNA was confirmed by 
RNaseR resistance (figure 39). In puromycin-treated myoblasts, 
circ-ZNF609 shifted to lighter polysomes, similarly to the 
behaviour of the linear ZNF609 and HPRT mRNAs, suggesting 
that its sedimentation pattern was due to active translation. A 
similar observation came from fractionation of mouse cell lysates 
(not shown). On the other hand, the fact that only a portion of the 
total circ-ZNF609 migrates with polysomes suggests that, besides 
the chance of a protein coding function, also a merely RNA-
dependent mechanism is possible.  
Since antibodies against the N-terminal and C-terminal portions of 
ZNF609 protein were available, we tested the presence of a circ-
ZNF609 encoded-peptide in human and mouse myoblasts. As 
shown in figure 40A, besides a band corresponding to the full-
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length ZNF609 recognized by both antibodies, the antibody 
targeting the ZNF609 N-terminus revealed a band compatible with 
a circRNA-encoded peptide (predicted weight 26 kDa, band 
observed between 25 and 30 kDa). Moreover, such band was 
down-regulated in response to circ-ZNF609 knock-down in both 
human and mouse cells (figure 40B). A protein-synthesis template 
without a 5-methyl-guanosyne cap is not a conventional mRNA. 
Internal ribosome entry sites (IRES) have been observed for viral 
and cellular transcripts, and if a natural circular RNA is translated, 
it has to contain an IRES by definition, as it lacks a 5’ end. 
Interestingly, the circ-ZNF609 sequence is significantly more 
conserved than the rest of the ZNF609 exons, mainly thanks to the 
contribution of the 5’ UTR region, which is roughly twice 
conserved among vertebrates with respect to the rest of ZNF609 5’ 
and 3’ UTRs (figure 41). We decided to clone the sequence 
spanning the head-to-tail splice junction of circ-ZNF609 until the 
AUG start codon in an IRES reporter vector that we produced. It is 
made of the juxtaposition of two luciferase-encoding ORFs 
(Firefly and Renilla), and a sequence that is to be tested for IRES 
activity cloned between those two ORFs. The luciferase activity of 
the two enzymes can be easily measured form cell lysates, 
therefore allowing fast and sensitive measurement of the two 
proteins concentration. The ratio Firefly/Renilla (F/R) can be then 
used as an estimate of the IRES activity of the sequence cloned in 
between, as the Renilla luciferase can be translated only if the 
ribosome is engaged after the Firefly stop codon. We compared the 
F/R ratio of 5 constructs: an empty vector (p-Luc), a vector 
containing the ZNF609 putative IRES sequence (p-Luc-UTR), a 
vector containing the same sequence with the addition of an 
artificial intron for reconstituting the splice junction of circZNF609 
(p-Luc-intr.-UTR), a splicing-mutant version of the latter (p-Luc-
intr.-UTR-Δ-spl.) and a positive control containing an IRES 
derived from the encephalomyocarditis virus (p-Luc-EMCV-
IRES). As shown in figure 42, the vector that produces the circ-
ZNF609 sequence after splicing makes a bicistronic mRNA 
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capable of potent IRES activity, even higher than the viral IRES 
that we tested. Interestingly, such activity was completely 
abolished after mutating the donor splice site, indicating that 
internal translation entirely depends on splicing. It is interesting to 
note the exact same RNA sequence, which has not experienced the 
splicing event, is not able to trigger translation of the Renilla 
luciferase. Therefore, if circ-ZNF609 is translated, it is likely that it 
depends on the Exon Junction Complex or any other modification 
that is deposited on the RNA as a consequence of splicing.  
Although these data altogether strongly indicate that circ-ZNF609 
can encode a functional protein, additional experiments are 
required for proving it unequivocally. Currently, we are producing 
plasmids that are able to encode stable artificial circular RNAs and 
we will use them to produce flag tag-containing circular ORFs, 
which should produce a flag tagged protein only if circularization 
is achieved. On the other hand, we are producing stable mouse 
embryonic stem cell clones carrying a flag tag-coding sequence 
immediately before the predicted stop codon of circ-ZNF609, 
inserted through the CRISPR/Cas9 technology. Finally, targeted 
mass spectrometry could confirm if the protein encoded by circ-
ZNF609 exists in a natural context. 
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Figure 37 
Figure 37. Schematic representation of the ZNF609 pre-mRNA (top), mRNA 
(middle) and exon 2 that can be circularized (bottom). The AUG and STOP 
codon are indicated. 
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Figure 38 
 
Figure 38. Cytoplasmic extracts from proliferating primary human myoblasts, 
either untreated (native, black lines) or treated with puromycin (grey lines), 
were loaded on 15-50% sucrose gradients and fractions measured by 
absorbance at 253 nm (light grey behind each plot). Fraction density decreases 
from left to right; the panels show one representative profile out of three 
independent biological replicates. Individual fractions were analysed by qRT-
PCR and represented as percentage of RNA level in each of the 12 fractions. 
Profiles are shown for circ-ZNF609 and ZNF609 mRNA. circ-PMS1 was used 
as a non translatable RNA, while HPRT is used as a positive control. 
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Figure 39 
 
Figure 39. RNaseR treatment of total RNA and polysome-bound RNA. Left 
panel: set-up of the treatment on total RNA with different amounts of enzyme. 
The percentage of the RNA, recovered after treatment and measured by qRT-
PCR, is shown. Right panel: RNase R treatment of polysome-bound RNA 
(obtained by sucrose fractionation): the percentage of recovery of circular and 
linear ZNF609 in control and RNase R treated samples is shown. 
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Figure 40 
 
Figure 40. Western Blot analysis of ZNF609-encoded proteins. A. Upper panel: 
schematic representation of the ZNF609 protein with the antibodies used in this 
work. Lower panels: Western blot analysis on human and mouse myoblast 
protein extracts with N-ter and C-ter targeting antibodies. B. Western blot 
analysis of human and mouse myoblasts treated with control and circ-ZNF609 
siRNAs. The black arrows show the predicted size of the full-length and the 
putative circ-ZNF609-encoded proteins. 
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Figure 41 
Figure 41. Conservation analysis of circ-ZNF609. Phylo-P-derived conservation 
score for 100 Vertebrates are shown in the bar plot, divided by the reading 
frame (aligned to the one of the ZNF609 mRNA ORF, +1 in dark, +2 in middle 
and +3 in light grey). Exon 2 (that produces circ-ZNF609) has been divided into 
the predicted 5’ UTR and the coding sequence (CDS). 
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Figure 42 
 
Figure 42. Luciferase analysis of 5 different constructs (represented in the upper 
panel) performed in mouse myoblasts in 5 biological replicates. Mean and 
standard deviation are shown in the bar plot. 3 asterisks correspond to a p-
value < 0.01 derived though Student’s t test with respect to the negative control 
(p-Luc). 
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Concluding Remarks 
 
 
As stated before in this thesis, the main aim of my work was to try 
to answer one simple question arising from several observations 
about circular RNAs expression in Eukaryotes: do these molecules 
do something? 
One example of functional circular RNA was previously identified 
(CDR1as/CiRS-7, Memczak et al., 2013 and Hansen et al., 2013), 
but it was and it is clear that it represents an exceptional molecule, 
with biosynthetic and molecular features significantly different 
from the rest of circular RNAs. Moreover, it is still not known 
whether this molecule impacts on a relevant biological process. 
The implications of knowing about circular RNAs functional 
capacities are many and important: these molecules are thousands 
or tens of thousands in human cells, they can be extremely 
abundant and their expression has already been observed to vary in 
response to physiological changes. They may be involved in 
development, disease, inheritance, ageing, signaling and whatever 
RNA-related phenomenon we can think about. Moreover, they can 
be turned into useful tools for biology and medicine, thanks to their 
exceptional stability and the easiness they can be produced with.  
In this work I tried to add a bit of information to the field, and 
achieved some specific and general pieces of knowledge that may 
result useful in the future. 
First of all, I studied and described the expression pattern of 
circular RNAs in muscle differentiation and found several features 
that may be generalized, in agreement with a few similar reports in 
different model systems. We now know that circular RNAs are 
globally regulated in differentiation and disease, such regulation 
occurs primarily at the transcriptional level and in second instance 
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at the splicing level. They are stable and can be accumulated over 
time. Their evolutionary conservation and conserved pattern of 
expression suggest that their production may be an evolutionary-
relevant event and they might be even functional on their own. 
Testing such functionality can be achieved by means of dedicated 
knock-down strategies and read-out tools, which indeed 
demonstrate that molecular phenotypes are associated with them. 
Finally, the specific case of circ-ZNF609 reveals for the first time 
that a circular RNA is definitely able to control relevant cellular 
activities - in this case cell division - and this is possibly due to 
protein-coding activity, a fact that may disclose an entire new 
fraction of the eukaryotic proteome that has not been explored so 
far. 
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Materials and Methods 
 
 
Cell culture and treatments. 
Mouse myoblasts (C2C12, ATCC) were cultured in Growth 
Medium (GM, DMEM supplemented with 20% FBS, L-
Glutammine 2 mM and Penicillin/Streptomycin) and induced to 
differentiate in Differentiation Medium (same as GM, but FBS 
reduced to 0.5%). Human myoblasts (9208 (wt) and 9981 (DMD), 
from Telethon Biobank) were cultured in Growth Medium (GM, 
DMEM supplemented with 10% FBS, L-Glutammine 2 mM, 
insulin 50 mg/ml, FGFb 25 ng/ml, EGGF 1 ng/ml, 
Penicillin/Streptomycin) and induced to differentiate by culturing 
in Human Skeletal Muscle Differentiation Medium (DM, 
Promocell). 
Reverse transfection of human myoblasts was performed as 
follows: 96-well format optical plates (Corning) were treated 
overnight with 350mg of Collagen Type I in water and 0.5% acetic 
acid, then washed with PBS and UV-sterilized. Twenty microliters 
of siRNA transfection mix (150 nM siRNA, 0.2 µl Dharmafect 
lipid reagent from Dharmacon, 20ml transfection medium: DMEM 
with L-glutammine 2mM and insulin 50 mg /ml) was seeded in 
each well, left at RT for 20 min and then diluted with 30 µl of 
transfection medium. Cells (12000 per well) were added in each 
well after resuspension in double complete medium (GM with 
double concentration of serum, antibiotics, FGFb and EGF). Cells 
were switched to DM after 24h. 
 
RNA isolation, treatments and analysis. 
Total RNA in this study was extracted with Qiazol reagent 
according to the manufacturer’s protocol (Qiagen). RNA from 96-
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well plates and nuclear/cytoplasmic fractions was purified with 
miRNEasy spin columns according to the manufacturer’s 
specifications (Qiagen). 
RNase R treatment was performed as follows: 1 or 6 µg of total 
RNA was diluted in 20 µl of water with 1 µl of RNase R and 2 µl 
of RNase R buffer (Epicentre), then incubated 15 min at 37°C and 
purified by phenol chloroform extraction. Ten picograms of a 
DNA spike-in molecule were added to each reaction for qPCR 
normalization. 
Retrotranscription of RNA in this study was achieved with VILO 
Superscript enzyme (Life Technologies): up to 2 µg of RNA was 
retrotranscribed in a 10-ml reaction mix with 1 µl of enzyme and 2 
µl of buffer, then incubated 10 min at 25°C, 60 min at 42°C and 5 
min at 85°C. 
qRT-PCR analyses in this study were performed as follows: cDNA 
(2-20 ng equivalent) was added to a reaction composed of 7.5 µl 
2X SYBR Mastermix (Qiagen), 1.5ml of 5mM primers and water 
to a final volume of 15 µl. DNA amplification (40 cycles of 95°C 
for 30 s, 55°C for 30 s and 72°C for 30 s, followed by melting 
curve analysis) was monitored with an ABI 7500 Fast qPCR 
instrument. 
RT-PCR for circRNA detection was performed with 0.2 µl of 
Mytaq DNA polymerase (Bioline) in 25 µl water with 5 µl reaction 
buffer, 15 ng of cDNA, 2.5µl 5mM primers. Reaction was carried 
out for up to 32 cycles at 95°C for 25 s, 55°C for 25 s, 72°C for 25 
s. Five microliters of final products were run on 2% agarose gels. 
All primers used in this study are reported in Supplementary Table 
1. RT-PCR for circular and linear RNA from the same locus was 
carried out for the same number of cycles. 
 
Western blot. 
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Cells were harvested with 50-100 µl of Protein Extraction Buffer 
(100 mM Tris pH7.5, EDTA 1 mM, SDS 2%, PIC1X (Complete, 
EDTA free, Roche) and incubated 20 min on ice , then centrifuged 
at 15000 x g for 15 min at 4°C. 15 µg of proteins were loaded on 4-
12 % bis-tris-acrylamide gel (Life technologies) and transferred to 
a nitrocellulose membrane. The membrane was blocked in 5 % 
milk and then hybridized with: 1.5 mg / ml anti-ZNF609 antibody 
(Sigma Aldrich, AV3178) for 2 hours at room temperature. Anti-
rabbit secondary antibody was used for detection after one-hour 
incubation at room temperature. 
 
RNAseq and circular RNA detection. 
Illumina TruSeq library preparation was performed by Istituto di 
Genomica Applicata (Udine, Italy) from 1µg of total RNA, 
depleted of ribosomal RNA with Ribominus technology (Life 
Technologies). For each sample, 20-40 million 100bp long paired-
end reads were sequenced (raw data available at GEO, accession 
number GSE70389), then trimmed and analysed as discussed in the 
text. Briefly, for standard gene expression analysis, reads were 
mapped with TopHat, transcriptomes defined by Cufflinks and 
differential expression called by Cuffdiff. For circRNA detection, 
paired-end reads were split and used separately as input to the 
following pipeline: reads were aligned to rRNA with Bowtie2, then 
remaining ones were mapped to hg19 or mm10 genome assemblies 
with Bowtie2. Reads remaining after these alignments were used 
as input to FindCirc (Memczak et al., 2013) for finding circRNAs. 
For quantitative analyses of circRNA regulation in human muscle 
differentiation, circRNAs with at least 5 reads in one sample were 
used. The total number of reads mapping to the head-to-tail splice 
junction was used for measuring circRNA expression level, while 
the mean of total reads mapping linearly to the same splice 
junction was used for measuring the abundance of the linear 
isoform. For comparing WT and DMD samples, circRNA 
expression level was normalized by dividing the reads mapping to 
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the head-to-tail junction by the total number of reads used for the 
analysis. 
After the circRNA detection process, all human circRNAs were 
annotated using bedtools to the Ensembl GRCh37 gene set. 
More details and all scripts are available upon request. 
 
Cell fractionation. 
Nuclear/cytoplasmic fractionation of human and mouse cells was 
performed according to Legnini et al. (34) as follows: cells (1 x 
106) were washed with PBS and immediately lysed on ice with 
500 ml of cytoplasmic lysis buffer (140 mM NaCl, 1.5 mM 
MgCl2, 10 mM Tris pH 7.5, 0.5% NP40) for 5 min. After scraping 
the cells and placing them in a 2-ml collection tube, 500 µl of a 
sucrose cushion (same as lysis buffer with 12% Sucrose) was 
gently pipetted to the bottom of the tube. Sample was centrifuged 
10 min at 12000 x g. Supernatant and pellet were then separately 
resuspended in 1 ml of Qiazol, while sucrose was discarded. RNA 
extraction was carried out as described above. 
Cytoplasm fractionations on sucrose gradients were performed as 
follows: 5x106 cells were lysed 5 min on ice with 500 ml of TNM 
(10 mM Tris pH 7.5, 10mM NaCl, 10 mM MgCl2) lysis buffer 
supplemented with 10 mg/ml cycloheximide, 1X PIC (Complete, 
EDTA free, Roche) and 1X RNase guard (Thermo Scientific), then 
spinned 2 min at 15000 x g for discarding nuclear pellets. Samples 
were centrifuged on 9 ml 15%-45% sucrose gradient at 38000 rpm 
with a SW41 rotor (Beckman) for 1 h 30 min at 4°C. Fractions 
were collected with a Bio-logic LP (Biorad), 0.001 ng of a spike-in 
DNA as internal control was added to each fraction, together with 
10 mg of glycogen, 100 mg of Proteinase K (Roche) and 40 ml of 
SDS. Samples were left 1 h at 37°C and RNA was purified by PCA 
extraction and precipitated with isopropanol. For puromycin 
treatments, medium was replaced 3 hours before lysis with 1 mM 
puromycin containing-medium. 
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Immunofluorescence and image analysis. 
Cells were washed twice in 100 ml PBS, fixed with 100 µl of 4% 
paraformaldehyde for 15 min at room temperature, washed twice 
with 100 µl of PBS, permeabilized and blocked with 100 µl of PBS 
with 0.2% Triton X-100 and 1% goat serum, incubated with 50 µl 
of in-house made anti-myogenin/anti-myosin antibody (available 
upon request), washed twice in PBS, incubated with 50 µl anti-
mouse Cy3/AlexaFluor488 secondary antibody diluted 1:300 in 
PBS-DAPI and finally washed twice in PBS. Acquisition for 
image-based phenotypic analysis was performed with a widefield 
Nikon TiE Microscope equipped with a Lumencor SpectraX LED 
light source and PerfectFocus 3; 4× and 10× objectives were used 
(Nikon Instruments). 
The acquired images were analysed using two custom image 
analysis algorithms (available upon request), developed and 
executed in the Acapella software development/run-time 
environment (Perkin Elmer). Both algorithms used a Perkin Elmer 
proprietary algorithm on the DAPI staining for nuclei detection. 
DAPI and MYOG staining at 48 h were used to extract (for each 
siRNA treatment) the total cell number, the percentage of MYOG+ 
cells, and the average MYOG signal intensity. The DAPI&MYOG 
algorithm workflow can be summarized as follows: 1) nuclei 
detection (on DAPI channel); 2) MYOG signal intensity estimation 
(from Cy3 channel) and 3) MYOG +/- nuclei classification. In the 
absence of a cytoplasmic marker, following the segmentation on 
DAPI, Voronoi tessellations were used to define local regions for 
each detected nucleus. Thus, foreground and background masks 
were defined to represent the nuclear area and its local background. 
These masks were further used to extract average DAPI and 
MYOG intensities for every nucleus. The standard deviations of 
MYOG intensity in the nuclei local background were estimated. 
The DAPI/MYOG signal intensity of every nucleus was defined as 
the difference between the DAPI/MYOG intensities of its local 
foreground and background. This local approach compensates for 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 97  
both intra- and inter-image spatial variability of illumination and 
minimizes possible errors in estimating DAPI/MYOG signal 
intensities over different wells (and fields). Following a similar 
local approach, and this time compensating for different inter-
image noise level/content, the MYOG-positive and -negative 
classification was developed to use a local image adaptive 
threshold to apply on the MYOG signal intensity. For each 
analysed image, the threshold was defined as 1.5*median of all 
standard deviations of MYOG signal intensities of the local 
backgrounds of all nuclei detected in the current image. Then, each 
nucleus was classified as MYOG+ or MYOG- based on the 
comparison of its MYOG signal intensity and the current local 
image threshold (see the example Figure showing the MYOG-
positive classification). 
DAPI and MHC staining at 96 h were used to extract (for each 
siRNA treatment) the total number of cells, the percentage of 
MHC-positive nuclei, and additional morphological parameters 
like the fusion index and the number of nuclei per fiber. The 
algorithm workflow can be summarized as follows: 1) nuclei 
detection (on DAPI channel); 2) nuclei count correction procedure; 
3) cytoplasm segmentation (on Red channel); 4) MHC signal 
intensity estimation (from the Red channel); 5) MHC-positive and 
-negative nuclei classification; 6) Red Cell/Fiber MHC+ nuclei 
classification. Prior to all analyses, a circular mask was applied on 
the images of all channels in order to remove vignetting.  
Following DAPI segmentation of the nuclei, we applied a nuclei 
count correction procedure. This was required to overcome the 
issue of contiguous, ‘syncytial-like’ nuclei that were present in 
myotubes. The nuclei count correction procedure was developed 
based on a combination of some morphological features of the 
detected nuclei: the normalized nuclear area (with respect to the 
median of all nuclei area of the current image) and the nuclear 
axial length ratio (nucleus width/length). We could distinguish 
three classes of nuclei. First, all nuclei having a normalized area 
smaller than 1, which count as 1 nucleus each. A second class was 
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defined by taking the integer of values derived after applying the 
floor function to nuclei with a normalized area greater than 1 (for 
example, nuclei with values between 2.0 and 2.99 were scored as 
2, while those between 3.0 and 3.99 were scored as 3). Third, we 
defined a subclass with all nuclei having a normalized area 
between 1.5 and 2 and with an axial length < 0.5 were counting as 
2 nuclei each.  
We used a Perkin Elmer proprietary algorithm to define the 
cytoplasmic area for each nucleus. The cytoplasmic area is 
assigned to the nuclei based on the signal in the Red channel. This 
was associated with two problems. First, because of the peculiar 
morphology of cells and fibers (cells have elongated shape, fibers 
appear stitched/clumpy and are multinucleated), individual 
cells/fibers were erroneously subdivided. Second, in some cases, 
the method attempted to assign cytoplasm to cells that, on visual 
inspection, had no signal in the Red channel. 
Thus, we defined a population of ‘cell’ objects including a nuclear 
region (with one or more nuclei) and a cytoplasmic region. All the 
detected ‘cell’ objects that had a cytoplasmic/nuclear area smaller 
than one were removed from the cytoplasmic segmentation result, 
since they were potentially MHC-negative. 
From the remaining population of cells, we defined a cellular mask 
(cytoplasm and nuclear areas) on which MHC-positive/negative 
nuclei classification was performed. All nuclei with at least one 
quarter of their area overlapping the cellular mask were classified 
as MHC-positive. All other nuclei were labelled as MHC-negative.  
The Red Cell/Fiber classification was implemented using a work-
around of the cytoplasm segmentation. The definition of a fiber 
was as follows: stitched/clumpy cells with multiple and short 
distanced nuclei (clusters). Red Cells were defined as elongated 
and mono-nucleate. We used the presence of nuclei clusters to 
differentiate between Red Cells and Fibers. Specifically, nuclei 
that were within 100 µm of each other were defined as being part 
of the same cluster. Thus, we used the morphological dilation 
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operator (circular structuring element of 30 pixels diameter) on the 
nuclear mask given by all MHC-positive nuclei. The resulting 
‘dilated’ mask was then intersected (‘AND’ operator) with the 
cellular mask to separate nuclei of neighbouring Red Cells. This 
resulting binary image was used to define nuclei clusters by using 
connected component labelling (D. H. Ballard and C. M. Brown, 
"Computer Vision," Prentice-Hall, 1982.) and selecting only those 
components containing more than one MHC-positive nucleus. 
Finally, all MHC-positive nuclei belonging to nuclei clusters were 
labelled as ‘Fiber nuclei’. Similarly, all those MHC-positive nuclei 
that were not part of a nuclear cluster are labelled as Red Cell 
nuclei. The result of this classification was transferred to the 
nuclei-associated ‘cell’ objects, and thus labeled as Fibers and Red 
Cells. 
For each well, this algorithm reports a set of 8 parameters. The first 
four parameters are based on nuclei, namely, total number of 
(detected) nuclei, percentage of MHC-positive nuclei, percentage 
of MHC-positive Red-Cell nuclei, average number of nuclei per 
Fiber (estimated by the average number of nuclei per nuclei 
cluster). The following two parameters are cell area descriptors: 
the fraction of Red Cell area and the fraction of Fibers area. These 
fractions were estimated as the total area of Red Cells/Fibers with 
respect to the entire area of the analysed image. Two additional 
parameters were implemented to better describe cellular 
phenotypes. The fusion index was defined as the fraction of total 
number of Fiber nuclei to the total number of detected nuclei. The 
maturation index was defined as the fraction of the total number of 
Fiber nuclei to the total number of MHC-positive nuclei. All raw 
images, segmentation results and scripts are available upon 
request.  
For BrdU staining, we used 5-Bromo-2’-deoxy-uridine Labeling 
and Detection kit I (Roche). Labeling reagent was added to the cell 
culture medium (diluted 1:1000) 3 hours before fixation (human 
primary myoblasts) or 15’ before fixation (C2C12), then cells were 
fixed with a solution made of 70% ethanol and 30% 50mM glycine 
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at pH 2.0 for 10 minutes at -20°C. Cells were then washed twice 
with PBS and incubated for 1 hour at room temperature with 30 µl 
of antibody anti-BrdU diluted 1:10 in PBS. Cells were again 
washed twice and incubated for 30 minutes with anti-mouse 
Cy3/AlexaFluor488 secondary antibody diluted 1:300 in PBS-
DAPI and finally washed twice in PBS. We took 4 pictures of each 
well with a Zeiss AXIO Observer A.1 with a 10X objective, both 
in the DAPI and Cy3 channels. These images were analysed 
manually by using ImageJ, by setting a fixed threshold for both 
DAPI and BrdU signal intensity and detecting nuclei with the 
built-in particle analysis plug-in. 
 
Statistical Analyses. 
All experiments were repeated for at least 3 times; arithmetic 
means together with standard error are reported in all bar plots 
shown in this study. Statistical significance for comparisons of 
means was assessed by Student’s T or Wilcoxon-Mann-Whitney U 
test depending on the data. P-values below 0.05 were marked by 1 
asterisk, while 2 asterisks indicate a p-value < 0.02 and 3 asterisks 
a p-value < 0.01. When multiple comparisons were performed, p-
values were scaled according to the Bonferroni correction and then 
filtered for corrected p-value < 0.1. 
 
PCR primers used in this study 
For each circular RNA was used a couple of divergent oligos 
named F1 and R1. For each linear RNA, an oligo in an external 
exon was coupled with one of the two divergent oligos (either R2 
with F1 or F2 with R1). 
HUMAN circular  
>hsaAcvr2aR1:CCAGGTAGCAAAACAATGCCGCC 
>hsaAcvr2aF1:GATGGCCTACCCTCCTGTACTTG 
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>hsaAnkib1R1:GATGAGTGCTTTACGGAATTTGGTGG 
>hsaAnkib1F1:GGCTCCTCTCTTTACTGCTGAAG 
>hsaAsh1lF1:GGTTGGCTATTGGAAGAACAGACCAG 
>hsaAsh1lR1:CTATCCACAGAGTCATCCCCAGAAG 
>hsaAsphF1:CAGATGATCCAGAACAAAAAGCAAAAG 
>hsaAsphR1:GCCTCCACAGGAACCTGCTCCTC 
>hsaMef2aR1:GTCCTCCGAGAGTGGACTGTGC 
>hsaMef2aF1:CTCACAGTGCCAAATGGAGCTGG 
>hsaMyl4R1:GCACTGGCCGTAGGTGATCTTC 
>hsaMyl4F1:GGGGATGTACTGCGGGCCCTG 
>hsaNebF1:GTGGACGCCATTCCCCTGTTG 
>hsaNebR1:GGAGTGCAGCATCTTGGGATCG 
>hsaPms1R1:CTTGAAAGGAGTCGAACTGTTGCC 
>hsaPms1F1:GATCTCCTCATGAGCTTTGGTATCC 
>hsaPtp4a2R1:GGAGTGACGACTTTGGTTCGAG 
>hsaPtp4a2F1:CTCGGTGTCCAGGAGTCTTC 
>hsaRtn4F1:CACTCAAGCAGAGATAGAGAGCATAG 
>hsaRtn4R1:GCAGCAGGAAGAGCAAAAAGGGTC 
>hsaRunx1F1:CTGCCTTTAACCCTCAGCCTCAG 
>hsaRunx1R1:GGCGACTTGCGGTGGGTTTGTG 
>hsaSeptR1:GTGGAGTTGGGTGTCTCGACC 
>hsaSeptF1:GAGCCTGCCCCTGTGTCTCAGC 
>hsaSlc8a1F1:CTGCCAGAGGTGGAGGGGAGG 
>hsaSlc8a1R1:GGTGGGTGAAAGACTTAATCGCCG 
>hsaTmeff1R1:GGCATGCACATTTCAAACCATCTCC 
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>hsaTmeff1F1:GCTGAGTGTGATGAAGATGCAG 
>hsaTtnF1:GAAGTGGCCCCTGTTCCTATCC 
>hsaTtnR1:CCTTATACCTGTGACTGACACCTCC 
>hsaCdylR1:AGGCTTAGCTGTTAACGGG 
>hsaCdylF1:CTGTTCCGGCTCCCAAGTGT 
>hsaZfp609F1:AAACCGGAGCCAGAGGAAGG 
>hsaZfp609R1:CAGCTATGTTCTCAGACCTGC 
>hsaBnc2F1:GTTCACTTGAAAGAGATGCACG 
>hsaBnc2R1:CTGAAGGGTGATGATTTCCTC 
>hsaMEd13lF1:CTTAACAGAATTGGATCATCTTGGGC 
>hsaMed13lR1:AATTAATCCCTGACTGAATTGGAAAGG 
>hsaCamsap1F1:CCAGTGTCAAGCGCTTCTCAAC 
>hsaCamsap1R1:GCTTGGACAGGAGAAGCTTGATAAC 
>hsaZfhx3R1:CGAGTCACAGCCTTCCATGGTAAGG 
>hsaZfhx3F1:CTACTACACCAACAGCCTGGAGAAG 
>hsaDcbld2R1:CGCGGATTTTTGGCCTCATACTC 
>hsaDcbld2F1:GGATGTAAGGGTTCCACTCTCAG 
>hsaAdamts6R1:CCCACCAAAGTGATGGAAACACC 
>hsaAdamts6F1:GGATGTTCCACTGTTTAAGAGCCAC 
>Convergent_circCRKL_fwd/hs:CTACCTGCAGTTTCCGGTTC 
>Convergent_circCRKL_rev/hs:GGTTGGGTGCTGAGACAGAT 
>hsaBach1F1:CAG AAC AGC TGG ATT GTA TCC 
>hsaBach1R1:GTTGTCGGGAAGTTCAGTGG 
>hsaRtn4bisF1:GTC TCT CCA GTA CAG GAG GTC 
>hsaRtn4bisR1:GAGGAGTTGGTTCAGAAGTAC 
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>hsaHipk3F1:CGGCCAGTCATGTATCAAAG 
>hsaHipk3R1:CCTGGAATACACAACTGCTTGG 
>hsaSpecc1F1:CTGTCTTGCAATGAGCTCAG 
>hsaSpecc1R1:TACTGAAAATTCCCGTGGGG 
>hsaZnf292F1:CCC AGG AAC CAT TGG ATA AG 
>hsaZnf292R1:CAGAGGTAAGATAAGGTCGG 
>hsaYYY-1F:ATGACCTGACATTGCTACTCC 
>hsaYYY-1R:CACAACAAAGGTGCTCCCAG 
 
linear-specific oligo (coupled with circular F1) 
>hsaAcvr2aR2:GACACAACCAAATCTTCCCCTTGC 
>hsaAnkib1R2:CAGTTCTCCGGGTTGGACATCC 
>hsaAsh1lR2:GCTGGGGTTTCAGAAGGACTGG 
>hsaAsphR2:CTGAGGGTATTTGCGTACTAGTTC 
>hsaMef2aR2:GACTTTGCCTAAGCTATTTGCACC 
>hsaMyl4R2:GGTGCCCTGCTCCTTGTTGC 
>hsaNebR2:GGAGTGCAGCATCTTTGGATCG 
>hsaPms1R2:GACTAGTGAAAGAGTGGTCTGC 
>hsaPtp4a2R2:GAGCGTTCAATTCCAAACAGC 
>hsaRtn4R2:GTCTCTCCAGTACAGGAGGTCAAC 
>hsaRunx1R2:GTAGGACTGATCGTAGGACCAC 
>hsaSeptR2:CTCTGGGGGTGTCGGCCATGTC 
>hsaSlc8a1R2:GGTTCCTCAAGCACAAGGGAG 
>hsaTmeff1R2:GCTTCTCGAACAAAACAGGGATTG 
>hsaTtnR2:CTTTTGGGGGAGCAGCAGGTTCC 
Ivano Legnini 
Pag 104  
>hsaCdylR2:CGATTGCGTTTCAGCGTGAG 
>hsaZfp609R2:CCATGATCTGCTCACAAGGAGA 
>hsaBnc2R2:CCATGTCATCGAGTTCTTTGG 
>hsaMed13lR2:TTTGAAGAGCAGCGTCCTACATTC 
>hsaCamsap1R2:TGAGCTGGACTTTCCAATAACTGTTG 
>hsaZfhx3R2:TTTCCCGTTGTTGCGCATGGCG 
>hsaDcbld2R2:CAGACAACCAGCTGGGCAGTAC 
>hsaAdamts6R2:GCTGCAGCTCCTTTCAGGCTC 
>Divergent_circCRKL_fwd/hs:GGTGTCCGAGAACTCGCGG 
>hsaBach1F2:CTGAGCTGGATTTAGCGAAG 
>hsaRtn4bisR2:GTAGGTTTGTGCAGTTACAGC 
>hsaHipk3R2:CTGATCATACTCCAAGGCTC 
>hsaSpecc1R2:AGCTGTTCGGCTTGGTGATC 
>hsaZnf292R2:CTGGATGGTCAGAACACAGC 
 
MOUSE circular  
>mmuAcvr2aF1:GGGTGTACAGACATCACAAGATGG 
>mmuAnkib1F1:GGCCCCAGGATCTTCGTAGG 
>mmuAnkib1R1:GTGCTTTGCGGAATTTGGTGGTTG 
>mmuAsh1lR1:GTGCTTTCTGATGATCGCTGGG 
>mmuAsh1lF1:GAACATAAGAAGGGGGTGAAGAGG 
>mmuAsphF1:GAACAGCAAGACACACCACCAG 
>mmuAsphR1:GAGTCTCTGCCTCCTCCTCCGGTG 
>mmuMef2aF1:GACCTCACGGTGCCAAATGGAGC 
>mmuMef2aR1:CCTCCGAGAGTGGACTGTGCTC 
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>mmuMyl4R1:CTGCCCGTAGGTGATCTTCATC 
>mmuMyl4F1:GTGGGGACGTGCTGCGGGCC 
>mmuNebF1:TACAAAGCAAAGCATGAAGGTGAG 
>mmuNebR1:CTTCTCCCAGTCTTGTTTGTAGAC 
>mmuPms1F1:CCTGAAACCTGATGTGAGGATTAC 
>mmuPms1R1:GAACTGGACAGGAGGCGAAC 
>mmuPtp4a2R1:CAACGTATATTCCAACGAAAAACC 
>mmuPtp4a2F1:GCTAGTTGCGCTTGCATTGATTG 
>mmuRtn4R1:GCAGGAAGAGCAAAAAGGGTCTC 
>mmuRtn4F1:GGGCAACATAGTTAAACCCAAAG 
>mmuRunx1F1:CTCAGCCTCAAAGTCAGATGCAG 
>mmuRunx1R1:GATGGCTCTATGGTAGGTGGC 
>mmuSeptR1:CAATCTCCTCGACTTCAAACGATCTC 
>mmuSeptF1:CCCAACTGTCCGCTCCCGTC 
>mmuSlc8a1F1:CACCTGTGGAGAGCTCGAATTCC 
>mmuSlc8a1R1:CCAGAGCTACCAGACGAAATCCC 
>mmuTmeff1R1:CATGCGCATTTCAAACCATCTCC 
>mmuTmeff1F1:GTGACGAGGATGCGGAGAACG 
>mmuTtnF1:CAGAAGAAGTGGTCCCTGTTCCC 
>mmuTtnR1:CCT GAG ACA GAC ACC TCT TCC TC 
>mmuCdylR1:GCACCAGATATTCTGTCTTCCC 
>mmuCdylF1:GTGACTGCTGCCATGGCCAC 
>mmuZfp609F1:GAAGGGGAGAATGAGTGCCG 
>mmuZfp609R1:GTC AAC GTC CCA CCT CAA GGT TC 
>mmuBnc2F1:GCTTCACTACAGGAACGTTCAC 
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>mmuBnc2R1:GCG GTC CAG TAC CTT GCC AG 
>mmuMEd13lR1:CTGAAATTATGGGTCCACAGTCC 
>mmuMed13lR1:CTGTGTGTATGGCGTCGTGATG 
>mmu1aCamsap1F1:CCTGTCCAGTGAGCTGTATTGCC 
>mmu2Camsap1R1:GAT GTA AAA CGG GTC TCG GAG G 
>mmuZfhx3R1:CATTGTCCTTCCCCGAGACGAC 
>mmuZfhx3F1:GTGCAACGCTTGTGACTACTAC 
>mmuDcbld2R1:GTAAGGGTTCCACTCTCAGG 
>mmuDcbld2F1:CAGTGCTGTTCATGAGTGGAAC 
>mmuAdamts6R1:GCCAAGCTCAGAGTGATAGG 
>mmuAdamts6F1:CCATTCTCTCCCACCAAAGTG 
>Convergent_circCRKL_fwd/mmu:CCTGAAGAGCAGTGGTG
GAG 
>Convergent_circCRKL_rev/mmu:GATGGCAAAGGGTTGATC
GC 
>mmuBach1R1:TATGCACAGAGGACTCGTAG 
>mmuBach1F1:AGT CGG AAA TCG AGA AGC TG 
>mmuRtn4bisF1:GAGGCGTCTCTTCTTAGTTGATG 
>mmuRtn4bisR1:GCCGTTACACTGACAATGCTG 
>mmuHipk3F1:GGATCGGCCAGTCATGTATC 
>mmuHipk3R1:CCGCTTGGCTCTACTTTGAG 
>mmuSpecc1F1:GTCTTGCACAGAGCTCAGACAAG 
>mmuSpecc1R1:GATAGTTACTGAGAGCTCCC 
>mmuZnf292F1:CTCCACTATCCTTTCCCAGG 
>mmuZnf292R1:CACTCAGAGGTAAGGTATGG 
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linear-specific oligo (coupled with circular F1)  
>mmuAnkibR2:CCGCTGGCAGCAGTTCTCTG 
>mmuAshlR2:CACAGGTTGCAAGGTATTTTCAGG 
>mmuAsphR2:CTTCAAATGCGTTCACTGCTTCC 
>mmuMef2aR2:CCTGGTGGCGGGGGAGACTTTG 
>mmuMyl4R2:CATCTCGAAGTCCAGTGTCTTGG 
>mmuNebR2:CACCTTGATGTCGAACTTCTTAGC 
>mmuPms1R2:CATTAGAGCCATCCTGTGATCTGG 
>mmuPtp4a2R2:CTCTGAAGCGTAACCGCATC 
>mmuRtn4R2:CTCTCCAGTACAGGAGGTCAAC 
>mmuRunxR2:GAAATGGGTGTCGCTGGGTG 
>mmuSeptR2:CAGCTGGGAGTCACCTCGGAG 
>mmuSlc8aR2:CTTTCTTCTCACTCATCTCCACC 
>mmuTmeffR2:GCTTTATACACGACGCTTCTCGG 
>mmuTtnR2:GGGCAGCTGGCTCTTTCTTCTTG 
>mmuCdylR2:CAC TGA AAC GCA ACC GCT TGT C 
>mmuZfp609R2:TGA CCA CTG GCA CTA ACA GG 
>mmuBnc2R2:CGATGCAGGTTTATATTGGCAC 
>mmuMed13lR2:GGC CAT TTT CCC AGA GTC CTT C 
>mmuCamsap1R2:GTGCTCTCGCCGATAACGGAC 
>mmuZfhx3R2:CGCCACTCTCATGCTGCTGC 
>mmuDcbld2R2:GCAAAAGGCAAAAGACAGCCAGC 
>mmuAdamts6R2:CACACATTCCAGCCACAGAGG 
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>Divergent_circCRKL_fwd/mmu:TCATGCGTATGCTCAACCT
C 
>Divergent_circCRKL_rev/mmu:TGCTGAGACAGAACCCACT
G 
>mmuBach1F2:GC GCA GAG GGA GTG AGT CAC 
>mmuRtn4bisR2:CAGGAATACTGAAGAGTGAGATC 
>mmuHipk3R2:CCAGTGACCACATGTCTATG 
>mmuSpecc1R2:CTGCTCAGCTGTTCTGCTTG 
>mmuZnf292R2:CAGCTTTGCTAGAGCGGTTG 
 
siRNAs used in this work 
circ-Acvr2a  dplx 1:UGUUCCAACUCAAGUGCUAUU 
 circ-Acvr2a  dplx 2:UUCCAACUCAAGUGCUAUAUU 
 circ-Ankib1  dplx 1:ACUUCGAGCUCAUGAAUGUUU 
 circ-Ankib1  dplx 2:UCAUGAAUGUGAAAGAUGUUU 
 circ-ASPH  dplx 1:GCAAAAGGACUUAAAGAGAUU 
 circ-ASPH  dplx 2:AAAAGGACUUAAAGAGAGAUU 
 circ-BACH1 dplx 1:GAAGCUGGUUGAUGAUAAUUU 
 circ-BACH1 dplx 2:AGAAGCUGGUUGAUGAUAAUU 
 circ-BNC2  dplx 1:GACAGGAUGCUGCUGGCAAUU 
 circ-BNC2  dplx 2:GCCGAAGCCGAGACAGGAUUU 
 circ-CAMSAP1  dplx 1:UGGAUCAACAAGAUAACAUUU 
 circ-CAMSAP1  dplx 2:GGAUCAACAAGAUAACAUCUU 
 circ-CDYL  dplx 1:UGUUAACGGGAAAGGUUGAUU 
 circ-CDYL  dplx 2:CGGGAAAGGUUGAAAGGAUUU 
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 circ-CRKL  dplx 1:UGGCAUUAGAGGUAUCCAAUU 
 circ-DCBLD2  dplx 1:AGAUAAACAAGGUGAUGGAUU 
 circ-DCBLD2  dplx 2:AUAAACAAGGUGAUGGAUGUU 
 circ-HIPK3  dplx 1:GGUACUACAGGUAUGGCCUUU 
 circ-HIPK3  dplx 2:AAUCUCGGUACUACAGGUAUU 
 circ-MED13L  dplx 1:GAGCUGAACUCACGGGAAUUU 
 circ-MED13L  dplx 2:AGAGCUGAACUCACGGGAAUU 
 circ-MYL4  dplx 1:CCUGAAGAGAUGAAGAUCAUU 
 circ-MYL4  dplx 2:GCCCAAGCCUGAAGAGAUGAA 
 circ-PMS1  dplx 1:GUACAUAACAAGCUGCUCUUU 
 circ-PTP4A2  dplx 1:GAAUCCACGUUCUAGUUUUUU 
 circ-QKI  dplx 1:UCUCUGAAGUUGUUGACCUUU 
 circ-QKI  dplx 2:AUUAUUGGUACCUGCAAAAUU 
 circ-RTN4  dplx 1:GAGUAAAACUUCAGAUGAGUU 
 circ-RTN4  dplx 2:AGUAAAACUUCAGAUGAGAUU 
 circ-RTN4bis  dplx 1:UCUCUGAAGUUGUUGACCUUU 
 circ-RTN4bis  dplx 2:UCUCUGAAGUUGUUGACCUUU 
 circ-Runx1  dplx 1:AGAGUCAGACUGAGGGGAAUU 
 circ-Runx1  dplx 2:AGUCAGAUGCAGGGGAAAAUU 
 circ-SEPT9  dplx 1:CAGGAGGCCUUGAAAAGAUUU 
 circ-SEPT9  dplx 2:AGCCAGGAGGCCUUGAAAAUU 
 circ-Slc8a1  dplx 1:UGAUGAAAUUGUUAGGUUGUU 
 circ-Slc8a1  dplx 2:AUUGUUAGGUUGUGACAGUUU 
 circ-Tmeff1  dplx 1:GCAGAAAAUGUUGGAAUUAUU 
 circ-Tmeff1  dplx 2:UGGAAUUAAAUGUGAGGGAUU 
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 circ-TTN  dplx 1:AAAAGUACCAGCUGUGCAUUU 
 circ-ZFHX3  dplx 1:CUGAAGUUGUACAAGGUCCUU 
 circ-ZNF292  dplx 1:GGAUAAAGACACUCCUAGAUU 
 circ-ZNF292  dplx 2:UUGGAUAAGGAUAAAGACAUU 
 circ-ZNF609  dplx 1:AGUCAAGUCUGAAAAGCAAUU 
 circ-ZNF609 dplx 2:UGAAAAGCAAUGAUGUUGUUU
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Glossary 
 
 
9208: human primary myoblasts deriving from the Telethon 
Biobank. 
Back-splicing: a particular splicing reaction generating head-to-
tail junctions. The result is a circular RNA. It can be triggered by 
base-pairing of the flanking introns or by RNA binding proteins. 
Bowtie: a program for fast mapping of ultra-high-throughput short 
sequencing reads. 
C2C12: mouse myoblasts cell line widely used in molecular and 
cellular studies. 
ceRNA: competing endogenous RNA; a transcript able to regulate 
other transcripts by binding to a similar pool of microRNAs. 
circRNA: circular RNA; covalently closed circular RNA molecule 
produced from linear precursors by the spliceosome in a reaction 
called back-splicing, in which the donor splice site is joined to an 
acceptor splice site located upstream of the donor. 
CRISPR/Cas9: Clustered regularly-interspaced short palindromic 
repeats (CRISPR) are short sequences in prokaryotic DNA that 
produce small RNAs able to function as guides for the protein 
Cas9, a DNA endonuclease that is responsible for a form of 
acquired immunity towards plasmids and phages. This bacterial 
immune system has been engineered very recently for realizing fast 
and efficient specific double strand breaks in eukaryotic DNA, 
which can be followed by homologous recombination in order to 
achieve precise gene editing (Jinek et al., eLife 2013). 
Cuffdiff: a program for identifying differentially expressed genes 
between different RNA-seq samples. It used TopHat alignment 
results. 
Ivano Legnini 
Pag 112  
Cufflinks: a program for reconstituting and quantitating the 
transcriptome in a RNA sample using the mapping results of 
TopHat. 
DM: differentiation medium; a cell culture medium used for 
inducing myoblast differentiation (see materials and methods). 
Head-to-tail junction: a splice junction generated by the process of 
back-splicing. It characterizes circular RNAs.  
DMD: Duchenne Muscular Dystrophy; a genetic disorder caused 
by the loss of dystrophin. 
Findcirc: a pipeline (and more stringently a script used in the 
pipeline) used for identifying head-to-tail splice junction from 
RNA-seq data. 
FPKM: Fragment per Kilobase of exon per Million fragments 
mapped. It is a unit for measuring transcript abundance, commonly 
calculated by Cufflinks and Cuffdiff. It corresponds to the number 
of reads mapped to a transcript, normalized for the length of the 
transcript and for the total reads mapped in the experiment. It can 
be corrected for multiple factors. 
GM: growth medium; a cell culture medium used for keeping 
myoblasts undifferentiated (see materials and methods). 
lincRNA: large intergenic non coding RNA; an RNA molecule 
larger than 200 nt, usually capped and polyadenylated, whose 
expression depends on an independent promoter recognised by 
RNA Pol II. 
microRNA: small RNA produced from a larger transcript by two 
subsequent endonucleolytic reactions catalyzed by Drosha and 
Dicer; it is then loaded onto the RNA induced silencing complex 
(RISC) binding to the proteins of the Argonaute (Ago) family; they 
function as a guide (due to partial Watson:Crick complementarity)  
for RISC to find its targets and repress their expression by either 
RNA degradation or trnaslation inhibition.. 
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MRF: myogenic regulatory factors; historically attributed to a 
group of transcription factors able to trigger and drive myogenesis. 
It could be attributed to microRNAs or other non-coding RNAs 
shown to play a role similar to those transcription factors. 
Myoblast: committed muscle progenitor cell able to proliferate 
and enter the differentiation program in response to external 
stimuli. 
Myogenesis: the process of muscle differentiation, usually referred 
to skeletal muscle. 
Myotube: syncytium of differentiated fused myoblasts. 
Paired-end: a feature of certain sequencing experiments in which 
cDNA fragments are sequenced from both termini. 
Ribominus/Ribozero: a group of methods (or the feature of RNA 
itself) for purifying RNA from ribosomal species, patent-protected 
by Thermofisher and Illumina respectively. 
RNA-seq: RNA sequencing. It denotes an ensemble of techniques 
used for high-throughput sequencing of cDNA libraries for the 
purpose of RNA quantification. It is often used referring to the 
Illumina system, a particular RNA-seq technology that is currently 
the most widely used worldwide.  
Sequencing read: the sequence of a fragment obtained by RNA-
seq technologies. It’s usually associated to an unique ID, a 
sequence, a quality score for each letter of the sequence and 
depending on the technology a set of coordinates identifying the 
position of the cDNA fragment in the support used for sequencing. 
siRNA: small interfering RNA; chemically identical to a 
microRNA, it is able to trigger its target degradation due to 
extensive (perfect) complementarity. 
TopHat: a program for mapping spliced reads. It uses the short 
read aligner Bowtie and then analyses the mapping results for 
retrieving splice junctions. 
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